1
|
Aly MM, Abdelaziz M, Alfaisal FA, Alrumian RA, Espinoza XAS, Gutiérrez-González R, García TK, Al Fattani A, Almohamady W, Al-Shoaibi AM. Multicenter External Validation of the Accuracy of Computed Tomography Criteria for Detecting Thoracolumbar Posterior Ligamentous Complex Injury. Neurosurgery 2025; 96:1236-1248. [PMID: 39636120 DOI: 10.1227/neu.0000000000003263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2024] [Accepted: 09/06/2024] [Indexed: 12/07/2024] Open
Abstract
BACKGROUND AND OBJECTIVE Recent studies have proposed computed tomography (CT) criteria for posterior ligamentous complex (PLC) injury: disrupted if ≥2 CT findings, indeterminate if single finding, and intact if 0 CT findings. The study aims to validate the CT criteria for PLC injury externally. METHODS Three level 1 trauma centers enrolled 614 consecutive patients with acute thoracolumbar fractures (T1-L5) who received CT and MRI. Three reviewers from each center assessed CT for facet joint malalignment, horizontal laminar fracture, spinous process fracture, and interspinous widening and MRI for disrupted PLC, defined as black stripe discontinuity. The primary outcome is the diagnostic accuracy of CT criteria (0, 1, ≥2 findings) in detecting disrupted PLC on MRI using all CT readings. A subgroup analysis was performed for each participating center and reviewer. The inter-reader agreement on PLC status on MRI and CT criteria was assessed using Fleiss Kappa ( k ). RESULTS The positive predictive value for PLC injury was 0 findings 3%, single positive CT 43%, and ≥2 CT findings in 94%. The accuracy measures were consistent across various centers and reviewers. The area under the curve for ≥1 CT finding in detecting PLC injury ranged from 90% to 97%, indicating excellent discrimination for all centers. The inter-reader k on PLC status by MRI and overall CT findings was substantial ( k > 0.60). CONCLUSION This study externally validates the previously proposed CT criteria for PLC injury. A total of ≥2 positive CT findings or 0 CT findings can be used as criteria for a disrupted PLC (B-type injury) or intact PLC (A-type injuries), respectively, without added MRI. A single CT finding implies indeterminate PLC status and the need for further MRI assessment. The CT criteria will potentially guide MRI indications and treatment decisions for neurologically intact thoracolumbar burst fractures.
Collapse
Affiliation(s)
- Mohamed M Aly
- Department of Neurosurgery, Mansoura University, Mansoura , Egypt
- Department of Neurosurgery, Prince Mohammed Bin Abdulaziz Hospital, Riyadh , Saudi Arabia
- Current Affiliation: Department of Neurosurgery, Prince Mohamed Ben Abdulaziz Hospital, Riyadh , Saudi Arabia
| | - Mohamed Abdelaziz
- Department of Orthopedic, King Saud Medical City, Riyadh , Saudi Arabia
- Department of Orthopedic, Mansoura University, Mansoura , Egypt
| | - Faisal A Alfaisal
- Department of Diagnostic Radiology, King Saud Medical City, Riyadh , Saudi Arabia
| | | | | | - Raquel Gutiérrez-González
- Department of Neurosurgery, University Hospital Puerta de Hierro Majadahonda, Madrid , Spain
- Department of Surgery, Faculty of Medicine, Autonomous University of Madrid, Madrid , Spain
| | - Teresa Kalantari García
- Department of Neurosurgery, University Hospital Puerta de Hierro Majadahonda, Madrid , Spain
| | - Areej Al Fattani
- Department of Biostatistics Epidemiology and Scientific Computing, King Faisal Specialist Hospital and Research Hospital, Riyadh , Saudi Arabia
| | - Waleed Almohamady
- Department of Neurosurgery, Prince Mohammed Bin Abdulaziz Hospital, Riyadh , Saudi Arabia
| | | |
Collapse
|
2
|
De Luca F, Suneson A, Kits A, Palmér E, Skare S, Delgado AF. Diagnostic Performance of Fast Brain MRI Compared with Routine Clinical MRI in Patients with Glioma Grades 3 and 4: A Pilot Study. AJNR Am J Neuroradiol 2025; 46:983-989. [PMID: 39477545 DOI: 10.3174/ajnr.a8558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Accepted: 10/25/2024] [Indexed: 04/19/2025]
Abstract
BACKGROUND AND PURPOSE EPIMix is a fast brain MRI technique not previously investigated in patients with grade 3 and 4 gliomas. This pilot study aimed to investigate the diagnostic performance of EPIMix in the radiological treatment evaluation of adult patients with grade 3 and 4 gliomas compared with routine clinical MRI (rcMRI). MATERIALS AND METHODS Patients with grade 3 and 4 gliomas investigated with rcMRI and EPIMix were retrospectively included in the study. Three readers (R1-R3) participated in the radiological assessment applying the Response Assessment for Neuro-Oncology (RANO 2.0) criteria, of whom two (R1 and R2) independently evaluated EPIMix and later rcMRI by measuring contrast-enhancing and non-contrast-enhancing tumor regions at each follow-up. For cases with discrepant evaluations, an unblinded side-by-side (EPIMix and rcMRI) reading was performed together with a third reader (R3). Comparisons between methods (EPIMix versus rcMRI) were performed using the weighted Cohen κ. The sensitivity and specificity to progressive disease (PD) on a follow-up scan were calculated for EPIMix compared with rcMRI with receiver operating characteristic curves (ROC) to assess the area under the curve (AUC). RESULTS Of 35 patients (mean age, 53 years; 31% women), a total of 93 MRIs encompassing 58 follow-up investigations showed PD at a blinded reading in 33% of EPIMix (19/58, R1-2), while in 31% (18/58 exams, R1), and 34% (20/58 exams, R2) of rcMRI. An almost perfect agreement for tumor category assessment was found between EPIMix and rcMRI (EPIMixR1 versus rcMRIR1 κ = 0.96; EPIMixR2 versus rcMRIR2 κ = 0.89). The sensitivity for EPIMix to detect PD was 1.00 (0.81-1.00) for R1 and 0.90 (0.68-0.99) for R2, while the specificity was 0.97 (0.86-1.00) for R1 and R2. The AUC for PD was 0.99 for R1 (EPIMixR1 versus rcMRIR1) and 0.94 for R2 (EPIMixR2 versus rcMRIR2). The P value of the DeLong test AUCR1 versus AUCR2 was P = .20 (R1-R2). CONCLUSIONS In this pilot study, EPIMix was used as a fast MRI alternative for treatment evaluation of patients with glioma grades 3 and 4, with high but slightly lower diagnostic performance than rcMRI.
Collapse
Affiliation(s)
- Francesca De Luca
- From the Department of Clinical Neuroscience (F.D.L., A.K., S.S., A.F.D.), Karolinska Institutet, Stockholm, Sweden
- Department of Radiology (F.D.L.), Karolinska University Hospital, Stockholm, Sweden
| | - Annika Suneson
- Department of Neuroradiology (A.S., A.K., S.S., A.F.D.), Karolinska University Hospital, Stockholm, Sweden
| | - Annika Kits
- From the Department of Clinical Neuroscience (F.D.L., A.K., S.S., A.F.D.), Karolinska Institutet, Stockholm, Sweden
- Department of Neuroradiology (A.S., A.K., S.S., A.F.D.), Karolinska University Hospital, Stockholm, Sweden
| | - Emilia Palmér
- Department of Medical Radiation Physics and Nuclear Medicine (E.P.), Karolinska University Hospital, Stockholm
- Department of Molecular Medicine and Surgery (E.P.), Karolinska Institutet, Stockholm, Sweden
| | - Stefan Skare
- From the Department of Clinical Neuroscience (F.D.L., A.K., S.S., A.F.D.), Karolinska Institutet, Stockholm, Sweden
- Department of Neuroradiology (A.S., A.K., S.S., A.F.D.), Karolinska University Hospital, Stockholm, Sweden
| | - Anna Falk Delgado
- From the Department of Clinical Neuroscience (F.D.L., A.K., S.S., A.F.D.), Karolinska Institutet, Stockholm, Sweden
- Department of Neuroradiology (A.S., A.K., S.S., A.F.D.), Karolinska University Hospital, Stockholm, Sweden
| |
Collapse
|
3
|
Wang Y, Zhang J, Li M, Miao Z, Wang J, He K, Yang Q, Zhang L, Mu L, Zhang H. SMART: Development and Application of a Multimodal Multi-organ Trauma Screening Model for Abdominal Injuries in Emergency Settings. Acad Radiol 2025; 32:2655-2666. [PMID: 39690074 DOI: 10.1016/j.acra.2024.11.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2024] [Revised: 11/19/2024] [Accepted: 11/21/2024] [Indexed: 12/19/2024]
Abstract
RATIONALE AND OBJECTIVES Effective trauma care in emergency departments necessitates rapid diagnosis by interdisciplinary teams using various medical data. This study constructed a multimodal diagnostic model for abdominal trauma using deep learning on non-contrast computed tomography (CT) and unstructured text data, enhancing the speed and accuracy of solid organ assessments. MATERIALS AND METHODS Data were collected from patients undergoing abdominal CT scans. The SMART model (Screening for Multi-organ Assessment in Rapid Trauma) classifies trauma using text data (SMART_GPT), non-contrast CT scans (SMART_Image), or both. SMART_GPT uses the GPT-4 embedding API for text feature extraction, whereas SMART_Image incorporates nnU-Net and DenseNet121 for segmentation and classification. A composite model was developed by integrating multimodal data via logistic regression of SMART_GPT, SMART_Image, and patient demographics (age and gender). RESULTS This study included 2638 patients (459 positive, 2179 negative abdominal trauma cases). A trauma-based dataset included 1006 patients with 1632 real continuous data points for testing. SMART_GPT achieved a sensitivity of 81.3% and an area under the receiver operating characteristic curve (AUC) of 0.88 based on unstructured text data. SMART_Image exhibited a sensitivity of 87.5% and an AUC of 0.81 on non-contrast CT data, with the average sensitivity exceeding 90% at the organ level. The integrated SMART model achieved a sensitivity of 93.8% and an AUC of 0.88. In emergency department simulations, SMART reduced waiting times by over 64.24%. CONCLUSION SMART provides rapid, objective trauma diagnostics, improving emergency care efficiency, reducing patient wait times, and enabling multimodal screening in diverse emergency contexts.
Collapse
Affiliation(s)
- Yaning Wang
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.)
| | - Jingfeng Zhang
- Department of Radiology, Ningbo No. 2 Hospital, Ningbo, 315010, China (J.Z.)
| | - Mingyang Li
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.)
| | - Zheng Miao
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.)
| | - Jing Wang
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.)
| | - Kan He
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.)
| | - Qi Yang
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.)
| | - Lei Zhang
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.)
| | - Lin Mu
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.)
| | - Huimao Zhang
- Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.).
| |
Collapse
|
4
|
Chen X, Dai C, Peng M, Wang D, Sui X, Duan L, Wang X, Wang X, Weng W, Wang S, Zhao H, Wang Z, Geng J, Chen C, Hu Y, Hu Q, Jiang C, Zheng H, Bao Y, Sun C, Cui Z, Zeng X, Han H, Xia C, Liu J, Yang B, Qi J, Ji F, Wang S, Hong N, Wang J, Chen K, Zhu Y, Yu F, Yang F. Artificial intelligence driven 3D reconstruction for enhanced lung surgery planning. Nat Commun 2025; 16:4086. [PMID: 40312393 PMCID: PMC12046031 DOI: 10.1038/s41467-025-59200-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Accepted: 04/14/2025] [Indexed: 05/03/2025] Open
Abstract
The increasing complexity of lung surgeries necessitates the need for enhanced imaging support to improve the precision and efficiency of preoperative planning. Despite the promise of 3D reconstruction, clinical adoption remains limited due to time constraints and insufficient validation. To address this, we evaluate an artificial intelligence-driven 3D reconstruction system for pulmonary vessels and bronchi in a retrospective, multi-center multi-reader multi-case study. Using a two-stage crossover design, ten thoracic surgeons assess 140 cases with and without the system's assistance. The system significantly improves the accuracy of anatomical variant identification by 8% (p < 0.01), reducing errors by 41%. Improvements in secondary endpoints are also observed. Operation procedure selection accuracy is improved by 8%, with a 35% decrease in errors. Preoperative planning time is decreased by 25%, and user satisfaction is high at 99%. These benefits are consistent across surgeons of varying experience. In conclusion, the artificial intelligence-driven 3D reconstruction system significantly improves the identification of anatomical variants, addressing a critical need in preoperative planning for thoracic surgery.
Collapse
Affiliation(s)
- Xiuyuan Chen
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Chenyang Dai
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
| | - Muyun Peng
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
| | - Dawei Wang
- Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China
| | - Xizhao Sui
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Liang Duan
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
| | - Xiang Wang
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
| | - Xun Wang
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Wenhan Weng
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Shaodong Wang
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Heng Zhao
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Zhenfan Wang
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Jiayi Geng
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Chen Chen
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
| | - Yan Hu
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
| | - Qikang Hu
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
| | - Chao Jiang
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
| | - Hui Zheng
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
| | - Yi Bao
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
| | - Chao Sun
- Department of Radiology, Peking University People's Hospital, Beijing, China
| | - Zhuoer Cui
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Xiangyu Zeng
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Huiming Han
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Chen Xia
- Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China
| | - Jinlong Liu
- Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China
| | - Bing Yang
- Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China
| | - Ji Qi
- Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China
| | - Fanghang Ji
- Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China
| | - Shaokang Wang
- Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China
| | - Nan Hong
- Department of Radiology, Peking University People's Hospital, Beijing, China
| | - Jun Wang
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Kezhong Chen
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China
| | - Yuming Zhu
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
| | - Fenglei Yu
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
| | - Fan Yang
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
- Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China.
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Peking University People's Hospital, Beijing, China.
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
- Beijing Key Laboratory of Innovative Application of Big Data in Lung Cancer, Peking University People's Hospital, Beijing, China.
| |
Collapse
|
5
|
Shi Z, Hu B, Lu M, Zhang M, Yang H, He B, Ma J, Hu C, Lu L, Li S, Ren S, Zhang Y, Li J, Nijiati M, Dong J, Wang H, Zhou Z, Zhang F, Pan C, Yu Y, Chen Z, Zhou CS, Wei Y, Zhou J, Zhang LJ, China Aneurysm AI Project Group. Development and Validation of a Sham-AI Model for Intracranial Aneurysm Detection at CT Angiography. Radiol Artif Intell 2025; 7:e240140. [PMID: 40105449 DOI: 10.1148/ryai.240140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/20/2025]
Abstract
Purpose To evaluate a sham-artificial intelligence (AI) model acting as a placebo control for a standard-AI model for diagnosis of intracranial aneurysm. Materials and Methods This retrospective crossover, blinded, multireader, multicase study was conducted from November 2022 to March 2023. A sham-AI model with near-zero sensitivity and similar specificity to a standard AI model was developed using 16 422 CT angiography examinations. Digital subtraction angiography-verified CT angiographic examinations from four hospitals were collected, half of which were processed by standard AI and the others by sham AI to generate sequence A; sequence B was generated in the reverse order. Twenty-eight radiologists from seven hospitals were randomly assigned to either sequence and then assigned to the other sequence after a washout period. The diagnostic performances of radiologists alone, radiologists with standard-AI assistance, and radiologists with sham-AI assistance were compared using sensitivity and specificity, and radiologists' susceptibility to sham AI suggestions was assessed. Results The testing dataset included 300 patients (median age, 61.0 years [IQR, 52.0-67.0]; 199 male), 50 of whom had aneurysms. Standard AI and sham AI performed as expected (sensitivity, 96.0% vs 0.0%; specificity, 82.0% vs 76.0%). The differences in sensitivity and specificity between standard AI-assisted and sham AI-assisted readings were 20.7% (95% CI: 15.8, 25.5 [superiority]) and 0.0% (95% CI: -2.0, 2.0 [noninferiority]), respectively. The difference between sham AI-assisted readings and radiologists alone was -2.6% (95% CI: -3.8, -1.4 [noninferiority]) for both sensitivity and specificity. After sham-AI suggestions, 5.3% (44 of 823) of true-positive and 1.2% (seven of 577) of false-negative results of radiologists alone were changed. Conclusion Radiologists' diagnostic performance was not compromised when aided by the proposed sham-AI model compared with their unassisted performance. Keywords: CT Angiography, Vascular, Intracranial Aneurysm, Sham AI Supplemental material is available for this article. Published under a CC BY 4.0 license. See also commentary by Mayfield and Romero in this issue.
Collapse
Affiliation(s)
- Zhao Shi
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
| | - Bin Hu
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
| | - Mengjie Lu
- Health Science Center, Ningbo University, Zhejiang, China
| | - Manting Zhang
- Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China
| | - Haiting Yang
- Department of Radiology, University Second Hospital, Lanzhou, China
| | - Bo He
- Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Jiyao Ma
- Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Chunfeng Hu
- Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - Li Lu
- Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - Sheng Li
- Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - Shiyu Ren
- Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - Yonggao Zhang
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Jun Li
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Mayidili Nijiati
- Image Center, The First People's Hospital of Kashi Prefecture, Kashi, China
| | - Jiake Dong
- Image Center, The First People's Hospital of Kashi Prefecture, Kashi, China
| | - Hao Wang
- Deepwise Artificial Intelligence (AI) Laboratory, Deepwise, Beijing, China
| | - Zhen Zhou
- Deepwise Artificial Intelligence (AI) Laboratory, Deepwise, Beijing, China
| | - Fandong Zhang
- Deepwise Artificial Intelligence (AI) Laboratory, Deepwise, Beijing, China
| | - Chengwei Pan
- Institute of Artificial Intelligence, Beihang University, Beijing, China
| | - Yizhou Yu
- Department of Computer Science, The University of Hong Kong, Hong Kong, China
| | - Zijian Chen
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
| | - Chang Sheng Zhou
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
| | - Yongyue Wei
- Center for Public Health and Epidemic Preparedness & Response, Peking University, Beijing, China
| | - Junlin Zhou
- Department of Radiology, University Second Hospital, Lanzhou, China
| | - Long Jiang Zhang
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
| | | |
Collapse
|
6
|
Hu B, He H, Shi Z, Wang L, Liu Q, Sun Z, Zhang L. Evaluating a clinically available artificial intelligence model for intracranial aneurysm detection: a multi-reader study and algorithmic audit. Neuroradiology 2025; 67:855-864. [PMID: 39812775 DOI: 10.1007/s00234-024-03536-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2024] [Accepted: 12/22/2024] [Indexed: 01/16/2025]
Abstract
PURPOSE We aimed to validate a clinically available artificial intelligence (AI) model to assist general radiologists in the detection of intracranial aneurysm (IA) in a multi-reader multi-case (MRMC) study, and to explore its performance in routine clinical settings. METHODS Two distinct cohorts of head CT angiography (CTA) data were assembled to validate an AI model. Cohort 1, comprising gold-standard consecutive CTA cases, was used in an MRMC study involving six board-certified general radiologists. Cohort 2, representing clinical CTA cases, was used to simulate a routine clinical setting. Following these evaluations, an algorithmic audit was conducted to identify any unusual or unexpected behaviors exhibited by the model. RESULTS Cohort 1 consisted of 131 CTA cases, while Cohort 2 included 515 CTA cases. In the MRMC study, the AI-assisted strategy demonstrated a significant improvement in aneurysm diagnostic performance, with the area under the receiver operating characteristic curve increasing from 0.815 (95%CI: 0.754-0.875) to 0.875 (95%CI: 0.831-0.921; p = 0.008). In the AI-based first-reader study, 60.4% of the CTA cases were identified as negative by the AI, with a high negative predictive value of 0.994 (95%CI: 0.977-0.999). The algorithmic audit highlighted two issues for improvement: the accurate detection of tiny aneurysms and the effective exclusion of false-positive lesions. CONCLUSION This study highlights the clinical utility of a high-performance AI model in detecting IAs, significantly improving general radiologists' diagnostic performance with the potential to reduce their workload in routine clinical practice. The algorithmic audit offers insights to guide the development and validation of future AI models.
Collapse
Affiliation(s)
- Bin Hu
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China
| | - Haitao He
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China
| | - Zhao Shi
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China
| | - Li Wang
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China
| | - Quanhui Liu
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China
| | - Zhiyuan Sun
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China.
| | - Longjiang Zhang
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China.
| |
Collapse
|
7
|
Dreizin D, Khatri G, Staziaki PV, Buch K, Unberath M, Mohammed M, Sodickson A, Khurana B, Agrawal A, Spann JS, Beckmann N, DelProposto Z, LeBedis CA, Davis M, Dickerson G, Lev M. Artificial intelligence in emergency and trauma radiology: ASER AI/ML expert panel Delphi consensus statement on research guidelines, practices, and priorities. Emerg Radiol 2025; 32:155-172. [PMID: 39714735 DOI: 10.1007/s10140-024-02306-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2024] [Accepted: 12/06/2024] [Indexed: 12/24/2024]
Abstract
BACKGROUND Emergency/trauma radiology artificial intelligence (AI) is maturing along all stages of technology readiness, with research and development (R&D) ranging from data curation and algorithm development to post-market monitoring and retraining. PURPOSE To develop an expert consensus document on best research practices and methodological priorities for emergency/trauma radiology AI. METHODS A Delphi consensus exercise was conducted by the ASER AI/ML expert panel between 2022-2024. In phase 1, a steering committee (7 panelists) established key themes- curation; validity; human factors; workflow; barriers; future avenues; and ethics- and generated an edited, collated long-list of statements. In phase 2, two Delphi rounds using anonymous RAND/UCLA Likert grading were conducted with web-based data capture (round 1) and a bespoke excel document with literature hyperlinks (round 2). Between rounds, editing and knowledge synthesis helped maximize consensus. Statements reaching ≥80% agreement were included in the final document. RESULTS Delphi rounds 1 and 2 consisted of 81 and 78 items, respectively.18/21 expert panelists (86%) responded to round 1, and 15 to round 2 (17% drop-out). Consensus was reached for 65 statements. Observations were summarized and contextualized. Statements with unanimous consensus centered around transparent methodologic reporting; testing for generalizability and robustness with external data; and benchmarking performance with appropriate metrics and baselines. A manuscript draft was circulated to panelists for editing and final approval. CONCLUSIONS The document is meant as a framework to foster best-practices and further discussion among researchers working on various aspects of emergency and trauma radiology AI.
Collapse
Affiliation(s)
- David Dreizin
- Emergency and Trauma Imaging, Department of Diagnostic Radiology and Nuclear Medicine, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD, USA.
| | - Garvit Khatri
- Abdominal Imaging, Department of Radiology, University of Colorado, Denver, CO, USA
| | - Pedro V Staziaki
- Cardiothoracic imaging, Department of Radiology, University of Vermont, Larner College of Medicine, Burlington, USA
| | - Karen Buch
- Neuroradiology imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA
| | | | - Mohammed Mohammed
- Abdominal imaging, Department of Radiology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
| | - Aaron Sodickson
- Mass General Brigham Enterprise Emergency Radiology, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA
| | - Bharti Khurana
- Trauma Imaging Research and innovation Center, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA
| | - Anjali Agrawal
- Department of Radiology, Teleradiology Solutions, Delhi, India
| | - James Stephen Spann
- Department of Radiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA
| | | | - Zachary DelProposto
- Division of Emergency Radiology, Department of Radiology, University of Michigan, Ann Arbor, MI, USA
| | | | - Melissa Davis
- Department of Radiology, Yale University, New Haven, CT, USA
| | | | - Michael Lev
- Emergency Radiology, Department of Radiology, Massachusetts General Hospial, Boston, USA
| |
Collapse
|
8
|
Robert D, Sathyamurthy S, Singh AK, Matta SA, Tadepalli M, Tanamala S, Bosemani V, Mammarappallil J, Kundnani B. Effect of Artificial Intelligence as a Second Reader on the Lung Nodule Detection and Localization Accuracy of Radiologists and Non-radiology Physicians in Chest Radiographs: A Multicenter Reader Study. Acad Radiol 2025; 32:1706-1717. [PMID: 39592384 DOI: 10.1016/j.acra.2024.11.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2024] [Revised: 10/25/2024] [Accepted: 11/01/2024] [Indexed: 11/28/2024]
Abstract
RATIONALE AND OBJECTIVES Missed nodules in chest radiographs (CXRs) are common occurrences. We assessed the effect of artificial intelligence (AI) as a second reader on the accuracy of radiologists and non-radiology physicians in lung nodule detection and localization in CXRs. MATERIALS AND METHODS This retrospective study using the multi-reader multi-case design included 300 CXRs acquired from 40 hospitals across the US. All CXRs had a paired follow-up image (chest CT or CXR) to augment the ground truth establishment for the presence and location of nodules on CXRs by five independent thoracic radiologists. 15 readers (nine radiologists and six non-radiology physicians) read each CXR twice in a second-reader paradigm, once without AI and then immediately with AI assistance. The primary analysis assessed the difference in area-under-the-alternative-free-response-receiver-operating-characteristic-curve (AFROC) of readers with and without AI. Case-level area-under-the-receiver-operating-characteristic-curve (AUROC), sensitivity, and specificity were assessed in secondary analyses. RESULTS A total of 300 CXRs (147 with nodules, 153 without nodules) from 300 patients (mean age, 64 years ± 15 [standard deviation]; 174 women) were included. The mean AFROC of readers was 0.73 without AI and 0.81 with AI (95% CI of difference, 0.05-0.10). Case-level AUROC was 0.77 without AI and 0.84 with AI (95% CI of difference, 0.04-0.09). Case-level sensitivity was 72.8% and 83.5% (95% CI of difference, 6.8-14.6) and specificity was 71.1% and 72.0% (95% CI of difference, -0.8-2.6) without and with AI, respectively. CONCLUSION Using AI, readers detected and localized more nodules without any significant difference in false positive interpretations.
Collapse
Affiliation(s)
- Dennis Robert
- Qure.ai Technologies Pvt. Ltd., Floor 2, Prestige Summit, Halasuru, Bangalore, Karnataka, India, 560042 (D.R., S.S., A.K.S., S.A.M., M.T., S.T.).
| | - Saigopal Sathyamurthy
- Qure.ai Technologies Pvt. Ltd., Floor 2, Prestige Summit, Halasuru, Bangalore, Karnataka, India, 560042 (D.R., S.S., A.K.S., S.A.M., M.T., S.T.)
| | - Anshul Kumar Singh
- Qure.ai Technologies Pvt. Ltd., Floor 2, Prestige Summit, Halasuru, Bangalore, Karnataka, India, 560042 (D.R., S.S., A.K.S., S.A.M., M.T., S.T.)
| | - Sri Anusha Matta
- Qure.ai Technologies Pvt. Ltd., Floor 2, Prestige Summit, Halasuru, Bangalore, Karnataka, India, 560042 (D.R., S.S., A.K.S., S.A.M., M.T., S.T.)
| | - Manoj Tadepalli
- Qure.ai Technologies Pvt. Ltd., Floor 2, Prestige Summit, Halasuru, Bangalore, Karnataka, India, 560042 (D.R., S.S., A.K.S., S.A.M., M.T., S.T.)
| | - Swetha Tanamala
- Qure.ai Technologies Pvt. Ltd., Floor 2, Prestige Summit, Halasuru, Bangalore, Karnataka, India, 560042 (D.R., S.S., A.K.S., S.A.M., M.T., S.T.)
| | - Vijay Bosemani
- Teleradiology Solutions, 22 Llanfair Rd UNIT 6, Ardmore, Pennsylvania 19003, USA (V.B.)
| | - Joseph Mammarappallil
- Department of Radiology, Duke University Hospital, 2301 Erwin Rd, Durham, North Carolina 27710, USA (J.M.)
| | - Bunty Kundnani
- Qure.ai Technologies Pvt. Ltd., Floor 6, Wing E, Times Square, Mumbai, Maharashtra, India, 400059 (B.K.)
| |
Collapse
|
9
|
DuPreez JA, McDermott O. The use of predetermined change control plans to enable the release of new versions of software as a medical device. Expert Rev Med Devices 2025; 22:261-275. [PMID: 39961588 DOI: 10.1080/17434440.2025.2468787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2024] [Accepted: 02/11/2025] [Indexed: 03/27/2025]
Abstract
OBJECTIVES This study investigates how Predetermined Change Control Plans (PCCPs) can support the Software Development Life Cycle (SDLC) of certain Software as a Medical Device (SaMD). METHODS Targeted surveys collected qualitative and quantitative data on the current regulatory change process for SaMD; the use of PCCPs; the potential parameters of PCCPs in terms of technical, clinical, usability, and administrative changes to SaMD; and whether PCCPs could be used more broadly for all SaMDs. RESULTS Results indicate that the current regulatory approach is not fit for purpose, specifically regarding fast-moving SaMD or continuous-learning AI SaMD. There was strong support for PCCPs to cover device technology, usability, and administrative changes, while clinical changes had limited support and required further investigation. The EU lags behind the US and now the UK in addressing these challenges and should look to legislate and implement PCCPs to ensure ongoing innovation and investment in digital health technologies. CONCLUSION This work is novel in the gathering of meaningful input from experts, practitioners, and regulatory professionals within the SaMD industry located in the EU, UK, and US on the value and need for PCCPs. This study has implications for practice and policy as it can inform SaMD guidance and legislation.
Collapse
Affiliation(s)
| | - Olivia McDermott
- College of Science & Engineering, University of Galway, Galway, Ireland
| |
Collapse
|
10
|
Reply. AJNR Am J Neuroradiol 2025; 46:456. [PMID: 39884833 DOI: 10.3174/ajnr.a8649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2025]
|
11
|
Smeets D. Letter to the Editor regarding "Automated Volumetric Software in Dementia: Help or Hindrance to the Neuroradiologist?". AJNR Am J Neuroradiol 2025; 46:454-455. [PMID: 39884831 DOI: 10.3174/ajnr.a8570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2025]
Affiliation(s)
- Dirk Smeets
- icometrixKolonel Begaultlaan 1b/12Leuven, Belgium
| |
Collapse
|
12
|
Li K, Yang Y, Yang Y, Li Q, Jiao L, Chen T, Guo D. Added value of artificial intelligence solutions for arterial stenosis detection on head and neck CT angiography: A randomized crossover multi-reader multi-case study. Diagn Interv Imaging 2025; 106:11-21. [PMID: 39299829 DOI: 10.1016/j.diii.2024.07.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2024] [Revised: 07/24/2024] [Accepted: 07/31/2024] [Indexed: 09/22/2024]
Abstract
PURPOSE The purpose of this study was to investigate the added value of artificial intelligence (AI) solutions for the detection of arterial stenosis (AS) on head and neck CT angiography (CTA). MATERIALS AND METHODS Patients who underwent head and neck CTA examinations at two hospitals were retrospectively included. CTA examinations were randomized into group 1 (without AI-washout-with AI) and group 2 (with AI-washout-without AI), and six readers (two radiology residents, two non-neuroradiologists, and two neuroradiologists) independently interpreted each CTA examination without and with AI solutions. Additionally, reading time was recorded for each patient. Digital subtraction angiography was used as the standard of reference. The diagnostic performance for AS at lesion and patient levels with four AS thresholds (30 %, 50 %, 70 %, and 100 %) was assessed by calculating sensitivity, false-positive lesions index (FPLI), specificity, and accuracy. RESULTS A total of 268 patients (169 men, 63.1 %) with a median age of 65 years (first quartile, 57; third quartile, 72; age range: 28-88 years) were included. At the lesion level, AI improved the sensitivity of all readers by 5.2 % for detecting AS ≥ 30 % (P < 0.001). Concurrently, AI reduced the FPLI of all readers and specifically neuroradiologists for detecting non-occlusive AS (all P < 0.05). At the patient level, AI improved the accuracy of all readers by 4.1 % (73.9 % [1189/1608] without AI vs. 78.0 % [1254/1608] with AI) (P < 0.001). Sensitivity for AS ≥ 30 % and the specificity for AS ≥ 70 % increased for all readers with AI assistance (P = 0.01). The median reading time for all readers was reduced from 268 s without AI to 241 s with AI (P< 0.001). CONCLUSION AI-assisted diagnosis improves the performance of radiologists in detecting head and neck AS, and shortens reading time.
Collapse
Affiliation(s)
- Kunhua Li
- Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University, 400010 Chongqing, PR China
| | - Yang Yang
- Department of Radiology, the First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, 400060 Chongqing, PR China
| | - Yongwei Yang
- Department of Radiology, the Fifth People's Hospital of Chongqing, 400062 Chongqing, PR China
| | - Qingrun Li
- Department of Radiology, Traditional Chinese Medicine Hospital of Dianjiang, 408300 Chongqing, PR China
| | - Lanqian Jiao
- Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University, 400010 Chongqing, PR China
| | - Ting Chen
- Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University, 400010 Chongqing, PR China
| | - Dajing Guo
- Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University, 400010 Chongqing, PR China.
| |
Collapse
|
13
|
Pesapane F, Hauglid MK, Fumagalli M, Petersson L, Parkar AP, Cassano E, Horgan D. The translation of in-house imaging AI research into a medical device ensuring ethical and regulatory integrity. Eur J Radiol 2025; 182:111852. [PMID: 39612599 DOI: 10.1016/j.ejrad.2024.111852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2024] [Revised: 11/15/2024] [Accepted: 11/25/2024] [Indexed: 12/01/2024]
Abstract
This manuscript delineates the pathway from in-house research on Artificial Intelligence (AI) to the development of a medical device, addressing critical phases including conceptualization, development, validation, and regulatory compliance. Key stages in the transformation process involve identifying clinical needs, data management, model training, and rigorous validation to ensure AI models are both robust and clinically relevant. Continuous post-deployment surveillance is essential to maintain performance and adapt to changes in clinical practice. The regulatory landscape is complex, encompassing stringent certification processes under the EU Medical Device Regulation (MDR) and the upcoming EU AI Act, which imposes additional compliance requirements aimed at mitigating AI-specific risks. Ethical considerations such as, emphasizing transparency, patient privacy, and equitable access to AI technologies, are paramount. The manuscript underscores the importance of interdisciplinary collaboration, between healthcare institutions and industry partners, and navigation of commercialization and market entry of AI devices. This overview provides a strategic framework for radiologists and healthcare leaders to effectively integrate AI into clinical practice, while adhering to regulatory and ethical standards, ultimately enhancing patient care and operational efficiency.
Collapse
Affiliation(s)
- Filippo Pesapane
- Breast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, Milan, Italy.
| | | | - Marzia Fumagalli
- Technology Transfer Office, IEO European Institute of Oncology IRCCS, Milan, Italy.
| | - Lena Petersson
- School of Health and Welfare, Halmstad University, Sweden.
| | - Anagha P Parkar
- Department of Radiology, Haraldsplass Deaconess Hospital, Bergen Norway; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.
| | - Enrico Cassano
- Breast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, Milan, Italy.
| | - Denis Horgan
- European Alliance for Personalised Medicine, Brussels, Belgium.
| |
Collapse
|
14
|
Brembilla G, Basile G, Cosenza M, Giganti F, Del Prete A, Russo T, Pennella R, Lavalle S, Raggi D, Mercinelli C, Tateo V, Cigliola A, Patanè D, Crupi E, Giannatempo P, Messina A, Calareso G, Martini A, Bandini M, Moschini M, Cardone G, Briganti A, Montorsi F, Necchi A, De Cobelli F. Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI. Radiology 2024; 313:e233020. [PMID: 39718497 DOI: 10.1148/radiol.233020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2024]
Abstract
Background An accurate method of assessing the response of muscle-invasive bladder cancer (MIBC) to neoadjuvant treatment is needed for selecting candidates for bladder-sparing strategies. Purpose To evaluate the diagnostic accuracy and reproducibility of neoadjuvant chemotherapy Vesical Imaging Reporting and Data System (nacVI-RADS) scores and posttreatment Vesical Imaging Reporting and Data System (VI-RADS) scores when assessing MIBC response to neoadjuvant immunotherapy with multiparametric MRI (mpMRI). Materials and Methods A retrospective analysis of MRI scans was conducted in patients enrolled in the PURE-01 study (NCT02736266) from February 2017 to December 2019 who underwent pre- and postimmunotherapy mpMRI before radical cystectomy. Five readers independently reviewed the scans using VI-RADS and nacVI-RADS criteria. Diagnostic accuracy was evaluated for each reader, and the final histopathologic diagnosis served as the reference standard. Interreader agreement was assessed with the percentage of agreement, Conger κ, and Gwet agreement coefficient AC1. Results A total of 110 patients (median age, 67 years [IQR: 61-74]; 96 male) with 220 MRI scans were included; 80 (73%) patients had pure urothelial carcinoma. A total of 46 of 110 (42%) patients achieved a complete pathologic response. The sensitivity, specificity, and negative predictive value of nacVI-RADS 3 or higher for detecting residual disease (higher than stage ypT0) at radical cystectomy were 67%-84%, 63%-96%, and 63%-75%, respectively; for residual muscle-invasive disease (higher than stage ypT1), these values were 91%-98%, 55%-94%, and 93%-98%, respectively. The accuracy of nacVI-RADS was 72%-81% for stage ypT0 or higher disease and 71%-95% for stage ypT1 or higher disease. The accuracy of VI-RADS 3 or higher was 80%-95% for stage ypT1 or higher disease. The percentage of agreement for nacVI-RADS scores was 82% (κ = 0.62-0.65; AC1 = 0.65). Conclusion The nacVI-RADS scores showed good accuracy and reproducibility when assessing MIBC response to neoadjuvant immunotherapy. © RSNA, 2024 Supplemental material is available for this article.
Collapse
Affiliation(s)
- Giorgio Brembilla
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Giuseppe Basile
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Michele Cosenza
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Francesco Giganti
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Andrea Del Prete
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Tommaso Russo
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Renato Pennella
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Salvatore Lavalle
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Daniele Raggi
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Chiara Mercinelli
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Valentina Tateo
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Antonio Cigliola
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Damiano Patanè
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Emanuele Crupi
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Patrizia Giannatempo
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Antonella Messina
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Giuseppina Calareso
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Alberto Martini
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Marco Bandini
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Marco Moschini
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Gianpiero Cardone
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Alberto Briganti
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Francesco Montorsi
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Andrea Necchi
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| | - Francesco De Cobelli
- From the Departments of Radiology (G. Brembilla, M.C., A.D.P., T.R., R.P., S.L., F.D.C.), Urology (G. Basile, M.B., M.M., A.B., F.M.), and Medical Oncology (D.R., C.M., V.T., A.C., D.P., E.C., A.N.), IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy (G. Brembilla, G. Basile, M.C., T.R., R.P., D.P., E.C., M.B., M.M., A.B., F.M., A.N., F.D.C.); Division of Surgery and Interventional Science, University College London, London, United Kingdom (F.G.); Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom (F.G.); Genitourinary Department, Programma Prostata (P.G.) and Department of Radiology (A. Messina, G. Calareso), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Tex (A. Martini); and Department of Radiology, IRCCS Ospedale San Raffaele-Turro, Milan, Italy (G. Cardone)
| |
Collapse
|
15
|
Aanestad E, Beniczky S, Olberg H, Brogger J. Unveiling variability: A systematic review of reproducibility in visual EEG analysis, with focus on seizures. Epileptic Disord 2024; 26:827-839. [PMID: 39340408 DOI: 10.1002/epd2.20291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2024] [Revised: 08/06/2024] [Accepted: 08/16/2024] [Indexed: 09/30/2024]
Abstract
OBJECTIVE Reproducibility is key for diagnostic tests involving subjective evaluation by experts. Our aim was to systematically review the reproducibility of visual analysis in clinical electroencephalogram (EEG). In this paper, we give data on the scope of EEG features found, and detailed reproducibility data for the most studied feature. METHODS We searched four databases for articles reporting reproducibility in clinical EEG, until June 2023. Two raters screened 24 553 citations, and then 2736 full texts. Quality was assessed according to the GRRAS guidelines. RESULTS We found 275 studies (268 interrater and 20 intrarater), addressing 606 different EEG features. Only 38 EEG features had been studied in >2 studies. Most studies had <50 patients and EEGs. The most often addressed feature was seizure detection (62 papers). Interrater reproducibility of seizure detection was substantial-to-almost-perfect with experienced raters and raw EEG (kappa .62-.88). With experienced raters and transformed EEG, reproducibility was substantial (kappa .63-.70). Inexperienced raters had lower reproducibility. Seizure lateralization reproducibility was moderate to substantial (kappa .58-.77) but lower than for seizure detection. SIGNIFICANCE Most EEG reproducibility studies are done only once. Intrarater studies are rare. The reproducibility of visual EEG analysis is variable. Interrater reproducibility for seizure detection is substantial-to-perfect with experienced raters and raw EEG, less with inexperienced raters or transformed EEG. The results of visual EEG analysis vary within the same rater, and between raters. There is a need for larger collaborative studies, using improved methodology, as well as more intrarater studies of EEG interpretation.
Collapse
Affiliation(s)
- Eivind Aanestad
- Department of Clinical Neurophysiology, Haukeland University Hospital, Bergen, Norway
- Department of Clinical Medicine, University of Bergen, Bergen, Norway
| | - Sándor Beniczky
- Danish Epilepsy Centre, Dianalund, Denmark and Aarhus University, Aarhus, Denmark
| | - Henning Olberg
- Department of Clinical Neurophysiology, Haukeland University Hospital, Bergen, Norway
| | - Jan Brogger
- Department of Clinical Neurophysiology, Haukeland University Hospital, Bergen, Norway
| |
Collapse
|
16
|
Bogaerts JMA, Steenbeek MP, Bokhorst J, van Bommel MHD, Abete L, Addante F, Brinkhuis M, Chrzan A, Cordier F, Devouassoux‐Shisheboran M, Fernández‐Pérez J, Fischer A, Gilks CB, Guerriero A, Jaconi M, Kleijn TG, Kooreman L, Martin S, Milla J, Narducci N, Ntala C, Parkash V, de Pauw C, Rabban JT, Rijstenberg L, Rottscholl R, Staebler A, Van de Vijver K, Zannoni GF, van Zanten M, de Hullu JA, Simons M, van der Laak JAWM. Assessing the impact of deep-learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes. J Pathol Clin Res 2024; 10:e70006. [PMID: 39439213 PMCID: PMC11496567 DOI: 10.1002/2056-4538.70006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2024] [Revised: 08/31/2024] [Accepted: 09/27/2024] [Indexed: 10/25/2024]
Abstract
In recent years, it has become clear that artificial intelligence (AI) models can achieve high accuracy in specific pathology-related tasks. An example is our deep-learning model, designed to automatically detect serous tubal intraepithelial carcinoma (STIC), the precursor lesion to high-grade serous ovarian carcinoma, found in the fallopian tube. However, the standalone performance of a model is insufficient to determine its value in the diagnostic setting. To evaluate the impact of the use of this model on pathologists' performance, we set up a fully crossed multireader, multicase study, in which 26 participants, from 11 countries, reviewed 100 digitalized H&E-stained slides of fallopian tubes (30 cases/70 controls) with and without AI assistance, with a washout period between the sessions. We evaluated the effect of the deep-learning model on accuracy, slide review time and (subjectively perceived) diagnostic certainty, using mixed-models analysis. With AI assistance, we found a significant increase in accuracy (p < 0.01) whereby the average sensitivity increased from 82% to 93%. Further, there was a significant 44 s (32%) reduction in slide review time (p < 0.01). The level of certainty that the participants felt versus their own assessment also significantly increased, by 0.24 on a 10-point scale (p < 0.01). In conclusion, we found that, in a diverse group of pathologists and pathology residents, AI support resulted in a significant improvement in the accuracy of STIC diagnosis and was coupled with a substantial reduction in slide review time. This model has the potential to provide meaningful support to pathologists in the diagnosis of STIC, ultimately streamlining and optimizing the overall diagnostic process.
Collapse
Affiliation(s)
- Joep MA Bogaerts
- Department of PathologyRadboud University Medical CenterNijmegenThe Netherlands
| | - Miranda P Steenbeek
- Department of Obstetrics and GynecologyRadboud University Medical CenterNijmegenThe Netherlands
| | - John‐Melle Bokhorst
- Department of PathologyRadboud University Medical CenterNijmegenThe Netherlands
| | - Majke HD van Bommel
- Department of Obstetrics and GynecologyRadboud University Medical CenterNijmegenThe Netherlands
| | - Luca Abete
- Diagnostic and Research Institute of PathologyMedical University of GrazGrazAustria
| | - Francesca Addante
- Pathology Unit, Department of Woman and Child's Health and Public Health SciencesFondazione Policlinico Universitario Agostino Gemelli IRCCSRomeItaly
| | | | - Alicja Chrzan
- Department of PathologyMaria Sklodowska‐Curie National Research Institute of OncologyWarsawPoland
| | - Fleur Cordier
- Department of PathologyGhent University HospitalGhentBelgium
| | | | | | - Anna Fischer
- Institute for Pathology and NeuropathologyUniversity of Tuebingen Medical Center IITuebingenGermany
| | - C Blake Gilks
- Department of Pathology and Laboratory MedicineUniversity of British Columbia and Vancouver General HospitalVancouverCanada
| | - Angela Guerriero
- General Pathology and Cytopathology Unit, Department of Medicine‐DMEDUniversity of PaduaPaduaItaly
| | - Marta Jaconi
- Department of PathologySan Gerardo HospitalMonzaItaly
| | - Tony G Kleijn
- Department of Pathology and Medical BiologyUniversity Medical Center GroningenGroningenThe Netherlands
| | - Loes Kooreman
- Department of Pathology, and GROW School for Oncology and ReproductionMaastricht University Medical Center+MaastrichtThe Netherlands
| | - Spencer Martin
- Department of Pathology and Laboratory MedicineUniversity of British Columbia and Vancouver General HospitalVancouverCanada
| | - Jakob Milla
- Institute for Pathology and NeuropathologyUniversity Hospital TübingenTübingenGermany
| | | | - Chara Ntala
- Department of PathologySt. George's University HospitalsLondonUK
| | - Vinita Parkash
- Department of PathologyYale School of Medicine and Yale School of Public HealthNew HavenCTUSA
| | - Christophe de Pauw
- Department of PathologyRadboud University Medical CenterNijmegenThe Netherlands
| | - Joseph T Rabban
- Department of PathologyUniversity of California San FranciscoSan FranciscoCAUSA
| | - Lucia Rijstenberg
- Department of PathologyErasmus University Medical CenterRotterdamThe Netherlands
| | - Robert Rottscholl
- Institute for Pathology and NeuropathologyUniversity of Tuebingen Medical Center IITuebingenGermany
| | - Annette Staebler
- Institute for Pathology and NeuropathologyUniversity of Tuebingen Medical Center IITuebingenGermany
| | - Koen Van de Vijver
- Department of Pathology, Cancer Research Institute Ghent (CRIG)Ghent University HospitalGhentBelgium
| | - Gian Franco Zannoni
- Pathology Unit, Department of Woman and Child's Health and Public Health SciencesFondazione Policlinico Universitario Agostino Gemelli IRCCSRomeItaly
| | - Monica van Zanten
- Department of PathologyJeroen Bosch Hospital's‐HertogenboschThe Netherlands
| | - Joanne A de Hullu
- Department of Obstetrics and GynecologyRadboud University Medical CenterNijmegenThe Netherlands
| | - Michiel Simons
- Department of PathologyRadboud University Medical CenterNijmegenThe Netherlands
| | - Jeroen AWM van der Laak
- Department of PathologyRadboud University Medical CenterNijmegenThe Netherlands
- Center for Medical Image Science and VisualizationLinköping UniversityLinköpingSweden
| |
Collapse
|
17
|
Marra A. G4 & the balanced metric family - a novel approach to solving binary classification problems in medical device validation & verification studies. BioData Min 2024; 17:43. [PMID: 39444008 PMCID: PMC11515465 DOI: 10.1186/s13040-024-00402-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2024] [Accepted: 10/15/2024] [Indexed: 10/25/2024] Open
Abstract
BACKGROUND In medical device validation and verification studies, the area under the receiver operating characteristic curve (AUROC) is often used as a primary endpoint despite multiple reports showing its limitations. Hence, researchers are encouraged to consider alternative metrics as primary endpoints. A new metric called G4 is presented, which is the geometric mean of sensitivity, specificity, the positive predictive value, and the negative predictive value. G4 is part of a balanced metric family which includes the Unified Performance Measure (also known as P4) and the Matthews' Correlation Coefficient (MCC). The purpose of this manuscript is to unveil the benefits of using G4 together with the balanced metric family when analyzing the overall performance of binary classifiers. RESULTS Simulated datasets encompassing different prevalence rates of the minority class were analyzed under a multi-reader-multi-case study design. In addition, data from an independently published study that tested the performance of a unique ultrasound artificial intelligence algorithm in the context of breast cancer detection was also considered. Within each dataset, AUROC was reported alongside the balanced metric family for comparison. When the dataset prevalence and bias of the minority class approached 50%, all three balanced metrics provided equivalent interpretations of an AI's performance. As the prevalence rate increased / decreased and the data became more imbalanced, AUROC tended to overvalue / undervalue the true classifier performance, while the balanced metric family was resistant to such imbalance. Under certain circumstances where data imbalance was strong (minority-class prevalence < 10%), MCC was preferred for standalone assessments while P4 provided a stronger effect size when evaluating between-groups analyses. G4 acted as a middle ground for maximizing both standalone assessments and between-groups analyses. CONCLUSIONS Use of AUROC as the primary endpoint in binary classification problems provides misleading results as the dataset becomes more imbalanced. This is explicitly noticed when incorporating AUROC in medical device validation and verification studies. G4, P4, and MCC do not share this limitation and paint a more complete picture of a medical device's performance in a clinical setting. Therefore, researchers are encouraged to explore the balanced metric family when evaluating binary classification problems.
Collapse
Affiliation(s)
- Andrew Marra
- Clinical Biostatistician at GE Healthcare, Chicago, IL, USA.
| |
Collapse
|
18
|
Balza R, Mercaldo SF, Huang AJ, Husseini JS, Jarraya M, Simeone FJ, Vicentini JRT, Palmer WE. Impact of Patient-reported Symptom Information on the Interpretation of MRI of the Lumbar Spine. Radiology 2024; 313:e233487. [PMID: 39470429 DOI: 10.1148/radiol.233487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/30/2024]
Abstract
Background Distinguishing lumbar pain generators from incidental findings at MRI can be difficult. Dictated reports may become lists of findings that cannot be ranked in order of diagnostic importance. Purpose To determine whether patient-reported symptom information can improve the interpretation of lumbar spine MRI by using the spine specialist as the reference standard. Materials and Methods This prospective, single-center, multireader study analyzed 240 participants who completed pre-MRI symptom questionnaires between May 2022 and February 2023. At the time of clinical MRI reporting, radiologists recorded pain generators in consecutive participants, creating two study groups by alternating interpretations with versus without symptom questionnaire results (SQR). Diagnostic certainty was recorded using a numeric scale of 0 to 100. Types, levels, and sides of pain generators were compared with reference diagnoses by calculating Cohen κ values with 95% CIs. Participant characteristics and diagnostic certainties were compared using the Wilcoxon rank sum, Pearson χ2, or Kruskal-Wallis test. Interrater agreement was analyzed. Results There was no difference in age (P = .69) or sex (P = .60) between participants using SQR (n = 120; mean age, 61.0 years; 62 female) and not using SQR (n = 120; mean age, 62.5 years; 67 female). When radiologists were compared with specialists, agreements on pain generators were almost perfect for interpretations using SQR (type: κ = 0.82 [95% CI: 0.74,0.89]; level: κ = 0.88 [95% CI: 0.80, 0.95]; side: κ = 0.84 [95% CI: 0.75, 0.92]), but only fair to moderate for interpretations not using SQR (type: κ = 0.26 [95% CI: 0.15, 0.36]; level: κ = 0.51 [95% CI: 0.39, 0.63]; side: κ = 0.30 [95% CI: 0.18, 0.42]) (all P < .001). Diagnostic certainty was higher for MRI interpretations using SQR (mean, 80.4 ± 14.9 [SD]) than MRI interpretations not using SQR (60.5 ± 17.7) (P < .001). Interrater agreements were substantial (κ = 0.65-0.78) for MRI interpretations using SQR but only fair to moderate (κ = 0.24-0.49) for MRI interpretations not using SQR (all P < .001). Conclusion Patient-reported symptom information enabled radiologists to achieve nearly perfect diagnostic agreement with clinical experts. © RSNA, 2024 See also the editorial by Isikbay and Shah in this issue.
Collapse
Affiliation(s)
- Rene Balza
- From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, YAW 6030, Boston, MA 02114
| | - Sarah F Mercaldo
- From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, YAW 6030, Boston, MA 02114
| | - Ambrose J Huang
- From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, YAW 6030, Boston, MA 02114
| | - Jad S Husseini
- From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, YAW 6030, Boston, MA 02114
| | - Mohamed Jarraya
- From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, YAW 6030, Boston, MA 02114
| | - F Joseph Simeone
- From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, YAW 6030, Boston, MA 02114
| | - Joao R T Vicentini
- From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, YAW 6030, Boston, MA 02114
| | - William E Palmer
- From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, YAW 6030, Boston, MA 02114
| |
Collapse
|
19
|
Apostolidis G, Kakouri A, Dimaridis I, Vasileiou E, Gerasimou I, Charisis V, Hadjidimitriou S, Lazaridis N, Germanidis G, Hadjileontiadis L. A web-based platform for studying the impact of artificial intelligence in video capsule endoscopy. Health Informatics J 2024; 30:14604582241296072. [PMID: 39441895 DOI: 10.1177/14604582241296072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2024]
Abstract
Objective: Integrating artificial intelligence (AI) solutions into clinical practice, particularly in the field of video capsule endoscopy (VCE), necessitates the execution of rigorous clinical studies. Methods: This work introduces a novel software platform tailored to facilitate the conduct of multi-reader multi-case clinical studies in VCE. The platform, developed as a web application, prioritizes remote accessibility to accommodate multi-center studies. Notably, considerable attention was devoted to user interface and user experience design elements to ensure a seamless and engaging interface. To evaluate the usability of the platform, a pilot study is conducted. Results: The results indicate a high level of usability and acceptance among users, providing valuable insights into the expectations and preferences of gastroenterologists navigating AI-driven VCE solutions. Conclusion: This research lays a foundation for future advancements in AI integration within clinical VCE practice.
Collapse
Affiliation(s)
- Georgios Apostolidis
- Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Antigoni Kakouri
- Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Ioannis Dimaridis
- Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Eleni Vasileiou
- Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Ioannis Gerasimou
- Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Vasileios Charisis
- Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Stelios Hadjidimitriou
- Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Nikolaos Lazaridis
- Division of Gastroenterology and Hepatology, First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Georgios Germanidis
- Division of Gastroenterology and Hepatology, First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Basic and Translational Research Unit, Special Unit for Biomedical Research and Education, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Leontios Hadjileontiadis
- Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Department of Biomedical Engineering, Khalifa University, Abu Dhabi, UAE
| |
Collapse
|
20
|
Pan Z, Qin Y, Bai W, He Q, Yin X, He J. Implementing multiple imputations for addressing missing data in multireader multicase design studies. BMC Med Res Methodol 2024; 24:217. [PMID: 39333923 PMCID: PMC11428558 DOI: 10.1186/s12874-024-02321-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2024] [Accepted: 08/27/2024] [Indexed: 09/30/2024] Open
Abstract
BACKGROUND In computer-aided diagnosis (CAD) studies utilizing multireader multicase (MRMC) designs, missing data might occur when there are instances of misinterpretation or oversight by the reader or problems with measurement techniques. Improper handling of these missing data can lead to bias. However, little research has been conducted on addressing the missing data issue within the MRMC framework. METHODS We introduced a novel approach that integrates multiple imputation with MRMC analysis (MI-MRMC). An elaborate simulation study was conducted to compare the efficacy of our proposed approach with that of the traditional complete case analysis strategy within the MRMC design. Furthermore, we applied these approaches to a real MRMC design CAD study on aneurysm detection via head and neck CT angiograms to further validate their practicality. RESULTS Compared with traditional complete case analysis, the simulation study demonstrated the MI-MRMC approach provides an almost unbiased estimate of diagnostic capability, alongside satisfactory performance in terms of statistical power and the type I error rate within the MRMC framework, even in small sample scenarios. In the real CAD study, the proposed MI-MRMC method further demonstrated strong performance in terms of both point estimates and confidence intervals compared with traditional complete case analysis. CONCLUSION Within MRMC design settings, the adoption of an MI-MRMC approach in the face of missing data can facilitate the attainment of unbiased and robust estimates of diagnostic capability.
Collapse
Affiliation(s)
- Zhemin Pan
- Tongji University School of Medicine, 1239 Siping Road, Yangpu District, Shanghai, 200092, China
| | - Yingyi Qin
- Department of Military Health Statistics, Naval Medical University, 800 Xiangyin Road, Yangpu District, Shanghai, 200433, China
| | - Wangyang Bai
- Tongji University School of Medicine, 1239 Siping Road, Yangpu District, Shanghai, 200092, China
| | - Qian He
- Department of Military Health Statistics, Naval Medical University, 800 Xiangyin Road, Yangpu District, Shanghai, 200433, China
| | - Xiaoping Yin
- Department of Radiology, the Affiliated Hospital of Hebei University, 212 Eastern Yuhua Road, Baoding City, Hebei Province, 071000, China
| | - Jia He
- Tongji University School of Medicine, 1239 Siping Road, Yangpu District, Shanghai, 200092, China.
- Department of Military Health Statistics, Naval Medical University, 800 Xiangyin Road, Yangpu District, Shanghai, 200433, China.
| |
Collapse
|
21
|
Brady AP, Allen B, Chong J, Kotter E, Kottler N, Mongan J, Oakden-Rayner L, Pinto Dos Santos D, Tang A, Wald C, Slavotinek J. Developing, Purchasing, Implementing and Monitoring AI Tools in Radiology: Practical Considerations. A Multi-Society Statement From the ACR, CAR, ESR, RANZCR & RSNA. J Am Coll Radiol 2024; 21:1292-1310. [PMID: 38276923 DOI: 10.1016/j.jacr.2023.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2024]
Abstract
Artificial intelligence (AI) carries the potential for unprecedented disruption in radiology, with possible positive and negative consequences. The integration of AI in radiology holds the potential to revolutionize healthcare practices by advancing diagnosis, quantification, and management of multiple medical conditions. Nevertheless, the ever-growing availability of AI tools in radiology highlights an increasing need to critically evaluate claims for its utility and to differentiate safe product offerings from potentially harmful, or fundamentally unhelpful ones. This multi-society paper, presenting the views of Radiology Societies in the USA, Canada, Europe, Australia, and New Zealand, defines the potential practical problems and ethical issues surrounding the incorporation of AI into radiological practice. In addition to delineating the main points of concern that developers, regulators, and purchasers of AI tools should consider prior to their introduction into clinical practice, this statement also suggests methods to monitor their stability and safety in clinical use, and their suitability for possible autonomous function. This statement is intended to serve as a useful summary of the practical issues which should be considered by all parties involved in the development of radiology AI resources, and their implementation as clinical tools. KEY POINTS.
Collapse
Affiliation(s)
| | - Bibb Allen
- Department of Radiology, Grandview Medical Center, Birmingham, Alabama; American College of Radiology Data Science Institute, Reston, Virginia
| | - Jaron Chong
- Department of Medical Imaging, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
| | - Elmar Kotter
- Department of Diagnostic and Interventional Radiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Nina Kottler
- Radiology Partners, El Segundo, California; Stanford Center for Artificial Intelligence in Medicine & Imaging, Palo Alto, California
| | - John Mongan
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, California
| | - Lauren Oakden-Rayner
- Australian Institute for Machine Learning, University of Adelaide, Adelaide, Australia
| | - Daniel Pinto Dos Santos
- Department of Radiology, University Hospital of Cologne, Cologne, Germany; Department of Radiology, University Hospital of Frankfurt, Frankfurt, Germany
| | - An Tang
- Department of Radiology, Radiation Oncology, and Nuclear Medicine, Université de Montréal, Montréal, Québec, Canada
| | - Christoph Wald
- Department of Radiology, Lahey Hospital & Medical Center, Burlington, Massachusetts; Tufts University Medical School, Boston, Massachusetts; Commision on Informatics, and Member, Board of Chancellors, American College of Radiology, Virginia
| | - John Slavotinek
- South Australia Medical Imaging, Flinders Medical Centre Adelaide, Adelaide, Australia; College of Medicine and Public Health, Flinders University, Adelaide, Australia
| |
Collapse
|
22
|
Kazimierczak W, Jedliński M, Issa J, Kazimierczak N, Janiszewska-Olszowska J, Dyszkiewicz-Konwińska M, Różyło-Kalinowska I, Serafin Z, Orhan K. Accuracy of Artificial Intelligence for Cervical Vertebral Maturation Assessment-A Systematic Review. J Clin Med 2024; 13:4047. [PMID: 39064087 PMCID: PMC11277636 DOI: 10.3390/jcm13144047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2024] [Revised: 07/03/2024] [Accepted: 07/08/2024] [Indexed: 07/28/2024] Open
Abstract
Background/Objectives: To systematically review and summarize the existing scientific evidence on the diagnostic performance of artificial intelligence (AI) in assessing cervical vertebral maturation (CVM). This review aimed to evaluate the accuracy and reliability of AI algorithms in comparison to those of experienced clinicians. Methods: Comprehensive searches were conducted across multiple databases, including PubMed, Scopus, Web of Science, and Embase, using a combination of Boolean operators and MeSH terms. The inclusion criteria were cross-sectional studies with neural network research, reporting diagnostic accuracy, and involving human subjects. Data extraction and quality assessment were performed independently by two reviewers, with a third reviewer resolving any disagreements. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool was used for bias assessment. Results: Eighteen studies met the inclusion criteria, predominantly employing supervised learning techniques, especially convolutional neural networks (CNNs). The diagnostic accuracy of AI models for CVM assessment varied widely, ranging from 57% to 95%. The factors influencing accuracy included the type of AI model, training data, and study methods. Geographic concentration and variability in the experience of radiograph readers also impacted the results. Conclusions: AI has considerable potential for enhancing the accuracy and reliability of CVM assessments in orthodontics. However, the variability in AI performance and the limited number of high-quality studies suggest the need for further research.
Collapse
Affiliation(s)
- Wojciech Kazimierczak
- Department of Radiology and Diagnostic Imaging, Collegium Medicum, Nicolaus Copernicus University in Torun, Jagiellońska 13-15, 85-067 Bydgoszcz, Poland
- Kazimierczak Private Medical Practice, Dworcowa 13/u6a, 85-009 Bydgoszcz, Poland
| | - Maciej Jedliński
- Department of Interdisciplinary Dentistry, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland
| | - Julien Issa
- Chair of Practical Clinical Dentistry, Department of Diagnostics, Poznań University of Medical Sciences, 61-701 Poznań, Poland
| | - Natalia Kazimierczak
- Kazimierczak Private Medical Practice, Dworcowa 13/u6a, 85-009 Bydgoszcz, Poland
| | | | - Marta Dyszkiewicz-Konwińska
- Chair of Practical Clinical Dentistry, Department of Diagnostics, Poznań University of Medical Sciences, 61-701 Poznań, Poland
| | - Ingrid Różyło-Kalinowska
- Department of Dental and Maxillofacial Radiodiagnostics, Medical University of Lublin, 20-093 Lublin, Poland
| | - Zbigniew Serafin
- Department of Radiology and Diagnostic Imaging, Collegium Medicum, Nicolaus Copernicus University in Torun, Jagiellońska 13-15, 85-067 Bydgoszcz, Poland
| | - Kaan Orhan
- Department of Dentomaxillofacial Radiology, Faculty of Dentistry, Ankara University, Ankara 06500, Turkey
- Medical Design Application and Research Center (MEDITAM), Ankara University, Ankara 06500, Turkey
- Department of Oral Diagnostics, Faculty of Dentistry, Semmelweis University, 1088 Budapest, Hungary
| |
Collapse
|
23
|
Brejnebøl MW, Lenskjold A, Ziegeler K, Ruitenbeek H, Müller FC, Nybing JU, Visser JJ, Schiphouwer LM, Jasper J, Bashian B, Cao H, Muellner M, Dahlmann SA, Radev DI, Ganestam A, Nielsen CT, Stroemmen CU, Oei EHG, Hermann KGA, Boesen M. Interobserver Agreement and Performance of Concurrent AI Assistance for Radiographic Evaluation of Knee Osteoarthritis. Radiology 2024; 312:e233341. [PMID: 38980184 DOI: 10.1148/radiol.233341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/10/2024]
Abstract
Background Due to conflicting findings in the literature, there are concerns about a lack of objectivity in grading knee osteoarthritis (KOA) on radiographs. Purpose To examine how artificial intelligence (AI) assistance affects the performance and interobserver agreement of radiologists and orthopedists of various experience levels when evaluating KOA on radiographs according to the established Kellgren-Lawrence (KL) grading system. Materials and Methods In this retrospective observer performance study, consecutive standing knee radiographs from patients with suspected KOA were collected from three participating European centers between April 2019 and May 2022. Each center recruited four readers across radiology and orthopedic surgery at in-training and board-certified experience levels. KL grading (KL-0 = no KOA, KL-4 = severe KOA) on the frontal view was assessed by readers with and without assistance from a commercial AI tool. The majority vote of three musculoskeletal radiology consultants established the reference standard. The ordinal receiver operating characteristic method was used to estimate grading performance. Light kappa was used to estimate interrater agreement, and bootstrapped t statistics were used to compare groups. Results Seventy-five studies were included from each center, totaling 225 studies (mean patient age, 55 years ± 15 [SD]; 113 female patients). The KL grades were KL-0, 24.0% (n = 54); KL-1, 28.0% (n = 63); KL-2, 21.8% (n = 49); KL-3, 18.7% (n = 42); and KL-4, 7.6% (n = 17). Eleven readers completed their readings. Three of the six junior readers showed higher KL grading performance with versus without AI assistance (area under the receiver operating characteristic curve, 0.81 ± 0.017 [SEM] vs 0.88 ± 0.011 [P < .001]; 0.76 ± 0.018 vs 0.86 ± 0.013 [P < .001]; and 0.89 ± 0.011 vs 0.91 ± 0.009 [P = .008]). Interobserver agreement for KL grading among all readers was higher with versus without AI assistance (κ = 0.77 ± 0.018 [SEM] vs 0.85 ± 0.013; P < .001). Board-certified radiologists achieved almost perfect agreement for KL grading when assisted by AI (κ = 0.90 ± 0.01), which was higher than that achieved by the reference readers independently (κ = 0.84 ± 0.017; P = .01). Conclusion AI assistance increased junior readers' radiographic KOA grading performance and increased interobserver agreement for osteoarthritis grading across all readers and experience levels. Published under a CC BY 4.0 license. Supplemental material is available for this article.
Collapse
Affiliation(s)
- Mathias W Brejnebøl
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Anders Lenskjold
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Katharina Ziegeler
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Huib Ruitenbeek
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Felix C Müller
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Janus U Nybing
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Jacob J Visser
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Loes M Schiphouwer
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Jorrit Jasper
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Behschad Bashian
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Haoyin Cao
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Maximilian Muellner
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Sebastian A Dahlmann
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Dimitar I Radev
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Ann Ganestam
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Camilla T Nielsen
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Carsten U Stroemmen
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Edwin H G Oei
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Kay-Geert A Hermann
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| | - Mikael Boesen
- From the Department of Radiology (M.W.B., A.L., F.C.M., J.U.N., D.I.R., C.T.N., M.B.), The Parker Institute (M.W.B., A.L., J.U.N., C.T.N., M.B.), and Department of Orthopaedic Surgery (C.U.S.), Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark; Radiologic AI Testcenter, Copenhagen, Denmark (M.W.B., A.L., F.C.M., J.U.N., C.T.N., M.B.); Departments of Radiology (K.Z., H.C., S.A.D., K.G.A.H.) and Orthopedic Surgery (B.B., M.M.), Charité Universitätsmedizin-Berlin, Berlin, Germany; Departments of Radiology & Nuclear Medicine (H.R., J.J.V., L.M.S., E.H.G.O.) and Orthopedic Surgery (J.J.), Erasmus MC, Rotterdam, the Netherlands; Department of Radiology, Herlev and Gentofte, Copenhagen, Denmark (F.C.M.); and Department of Orthopedic Surgery, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark (A.G.)
| |
Collapse
|
24
|
Park S, Park HS, Jang S, Cho J, Kim JH, Yu MH, Jung SI, Kim YJ, Hwang DY. Utility of abbreviated MRI in the post-treatment evaluation of rectal cancer. Acta Radiol 2024; 65:689-699. [PMID: 38778748 DOI: 10.1177/02841851241253936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2024]
Abstract
BACKGROUND Post-treatment evaluation of patients with rectal cancer (RC) using magnetic resonance imaging (MRI) burdens medical resources, necessitating an exploration of abbreviated protocols. PURPOSE To evaluate the diagnostic performance of abbreviated MRI (A-MRI) for the post-treatment evaluation of RC patients. MATERIAL AND METHODS This retrospective study included RC patients who underwent non-contrast rectal MRI and standard liver MRI, as well as abdominal contrast-enhanced computed tomography (CECT) for post-treatment evaluation. A-MRI comprised diffusion-weighted imaging (DWI) and T2-weighted imaging of the upper abdomen and the pelvic cavity. Three radiologists independently reviewed A-MRI, CECT, and standard liver MRI in the detection of viable disease. The diagnostic performances were compared using a reference standard considering all available information, including pathology, FDG-PET, endoscopic results, and clinical follow-up. RESULTS We included 78 patients (50 men, 28 women; mean age=60.9 ± 10.2 years) and observed viable disease in 34 (43.6%). On a per-patient-basis analysis, A-MRI showed significantly higher sensitivity (95% vs. 81%, P = 0.04) and higher accuracy (93% vs. 82%, P < 0.01), compared to those of CECT, while A-MRI showed comparable sensitivity (91% vs. 91%, P = 0.42) and accuracy (97% vs. 98%, P = 0.06) to that of standard liver MRI. On a per-lesion-based analysis, A-MRI exhibited significantly superior lesion detectability than that of CECT (figure of merit 0.91 vs. 0.77, P < 0.01) and comparable to that of standard liver MRI (figure of merit 0.91 vs. 0.92, P = 0.75). CONCLUSION A-MRI exhibited higher sensitivity and diagnostic accuracy than those of CECT in the post-treatment evaluation of RC, while it showed comparable performances with standard liver MRI. A-MRI provides diagnostic added value in the follow-up of RC patients.
Collapse
Affiliation(s)
- Sungeun Park
- Department of Radiology, Konkuk University Medical Center, Seoul, Republic of Korea
| | - Hee Sun Park
- Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
| | - Siwon Jang
- Department of Radiology, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea
| | - Jungheum Cho
- Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
| | - Jae Hyun Kim
- Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea
| | - Mi Hye Yu
- Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
| | - Sung Il Jung
- Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
| | - Young Jun Kim
- Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
| | - Dae-Yong Hwang
- Department of Surgery, Colorectal Cancer Center, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
| |
Collapse
|
25
|
van der Pol CB, Costa AF, Lam E, Dawit H, Bashir MR, McInnes MDF. Best Practice for MRI Diagnostic Accuracy Research With Lessons and Examples from the LI-RADS Individual Participant Data Group. J Magn Reson Imaging 2024; 60:21-28. [PMID: 37818955 DOI: 10.1002/jmri.29049] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 09/26/2023] [Accepted: 09/27/2023] [Indexed: 10/13/2023] Open
Abstract
Medical imaging diagnostic test accuracy research is strengthened by adhering to best practices for study design, data collection, data documentation, and study reporting. In this review, key elements of such research are discussed, and specific recommendations provided for optimizing diagnostic accuracy study execution to improve uniformity, minimize common sources of bias and avoid potential pitfalls. Examples are provided regarding study methodology and data collection practices based on insights gained by the liver imaging reporting and data system (LI-RADS) individual participant data group, who have evaluated raw data from numerous MRI diagnostic accuracy studies for risk of bias and data integrity. The goal of this review is to outline strategies for investigators to improve research practices, and to help reviewers and readers better contextualize a study's findings while understanding its limitations. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY: Stage 3.
Collapse
Affiliation(s)
- Christian B van der Pol
- Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada
- McMaster University, Hamilton, Ontario, Canada
| | - Andreu F Costa
- Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada
| | - Eric Lam
- Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada
| | - Haben Dawit
- Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada
- Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Mustafa R Bashir
- Departments of Radiology and Medicine, Duke University Medical Center, Durham, North Carolina, USA
- Center for Advanced Magnetic Resonance Development, Duke University Medical Center, Durham, North Carolina, USA
- Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, USA
| | - Matthew D F McInnes
- Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada
- Rm c-159 Departments of Radiology and Epidemiology, The Ottawa Hospital-Civic Campus, Ottawa, Ontario, Canada
| |
Collapse
|
26
|
Benomar A, Diestro JDB, Darabid H, Saydy K, Tzaneva L, Li J, Zarour E, Tanguay W, El Sayed N, Padilha IG, Létourneau-Guillon L, Bard C, Nelson K, Weill A, Roy D, Eneling J, Boisseau W, Nguyen TN, Abdalkader M, Najjar AA, Nehme A, Lemoine É, Jacquin G, Bergeron D, Brunette-Clément T, Chaalala C, Bojanowski MW, Labidi M, Jabre R, Ignacio KHD, Omar AT, Volders D, Dmytriw AA, Hak JF, Forestier G, Holay Q, Olatunji R, Alhabli I, Nico L, Shankar JJS, Guenego A, Pascual JLR, Marotta TR, Errázuriz JI, Lin AW, Alves AC, Fahed R, Hawkes C, Lee H, Magro E, Sheikhi L, Darsaut TE, Raymond J. Nonaneurysmal perimesencephalic subarachnoid hemorrhage on noncontrast head CT: An accuracy, inter-rater, and intra-rater reliability study. J Neuroradiol 2024; 51:101184. [PMID: 38387650 DOI: 10.1016/j.neurad.2024.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Revised: 02/13/2024] [Accepted: 02/15/2024] [Indexed: 02/24/2024]
Abstract
BACKGROUND AND PURPOSE To evaluate the reliability and accuracy of nonaneurysmal perimesencephalic subarachnoid hemorrhage (NAPSAH) on Noncontrast Head CT (NCCT) between numerous raters. MATERIALS AND METHODS 45 NCCT of adult patients with SAH who also had a catheter angiography (CA) were independently evaluated by 48 diverse raters; 45 raters performed a second assessment one month later. For each case, raters were asked: 1) whether they judged the bleeding pattern to be perimesencephalic; 2) whether there was blood anterior to brainstem; 3) complete filling of the anterior interhemispheric fissure (AIF); 4) extension to the lateral part of the sylvian fissure (LSF); 5) frank intraventricular hemorrhage; 6) whether in the hypothetical presence of a negative CT angiogram they would still recommend CA. An automatic NAPSAH diagnosis was also generated by combining responses to questions 2-5. Reliability was estimated using Gwet's AC1 (κG), and the relationship between the NCCT diagnosis of NAPSAH and the recommendation to perform CA using Cramer's V test. Multi-rater accuracy of NCCT in predicting negative CA was explored. RESULTS Inter-rater reliability for the presence of NAPSAH was moderate (κG = 0.58; 95%CI: 0.47, 0.69), but improved to substantial when automatically generated (κG = 0.70; 95%CI: 0.59, 0.81). The most reliable criteria were the absence of AIF filling (κG = 0.79) and extension to LSF (κG = 0.79). Mean intra-rater reliability was substantial (κG = 0.65). NAPSAH weakly correlated with CA decision (V = 0.50). Mean sensitivity and specificity were 58% (95%CI: 44%, 71%) and 83 % (95%CI: 72 %, 94%), respectively. CONCLUSION NAPSAH remains a diagnosis of exclusion. The NCCT diagnosis was moderately reliable and its impact on clinical decisions modest.
Collapse
Affiliation(s)
- Anass Benomar
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. https://twitter.com/AnassBenomarMD
| | - Jose Danilo B Diestro
- Division of Diagnostic and Therapeutic Neuroradiology, Department of Radiology, St. Michael's Hospital, University of Toronto, ON, Canada. https://twitter.com/DanniDiestro
| | - Houssam Darabid
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Karim Saydy
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Lora Tzaneva
- Department of Experimental Surgery, McGill University, Montreal, QC, Canada
| | - Jimmy Li
- Division of Neurology, Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke, QC, Canada. https://twitter.com/neuroloJimmy
| | - Eleyine Zarour
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. https://twitter.com/eleyine
| | - William Tanguay
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Nohad El Sayed
- Department of Radiology, McGill University Health Centre (MUHC), Montreal, QC, Canada
| | - Igor Gomes Padilha
- Division of Neuroradiology, Diagnósticos da América SA - DASA, São Paulo, SP, Brazil; Division of Neuroradiology, Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil; Division of Neuroradiology, United Health Group, São Paulo, SP, Brazil
| | - Laurent Létourneau-Guillon
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. https://twitter.com/LaurentLetG
| | - Céline Bard
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Kristoff Nelson
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Alain Weill
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Daniel Roy
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Johanna Eneling
- Department of Neurosurgery, Linköping University Hospital, Linköping, Sweden
| | - William Boisseau
- Department of Interventional Neuroradiology, Fondation Adolphe de Rothschild, Paris, France
| | - Thanh N Nguyen
- Department of Neurology, Neurosurgery, and Radiology, Boston Medical Center, Boston, MA, USA. https://twitter.com/NguyenThanhMD
| | - Mohamad Abdalkader
- Department of Neurology, Neurosurgery, and Radiology, Boston Medical Center, Boston, MA, USA. https://twitter.com/AbdalkaderMD
| | - Ahmed A Najjar
- Division of Neurosurgery, Department of Surgery, College of Medicine, Taibah University, Medina, Saudi Arabia. https://twitter.com/AhmedANajjar
| | - Ahmad Nehme
- Université Caen-Normandie, Neurology, CHU Caen-Normandie, Caen, France. https://twitter.com/ANehme
| | - Émile Lemoine
- Division of Neurology, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. https://twitter.com/lemoineemile
| | - Gregory Jacquin
- Division of Neurology, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - David Bergeron
- Division of Neurosurgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. https://twitter.com/David__Bergeron
| | - Tristan Brunette-Clément
- Division of Neurosurgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. https://twitter.com/BrunetteClement
| | - Chiraz Chaalala
- Division of Neurosurgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Michel W Bojanowski
- Division of Neurosurgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Moujahed Labidi
- Division of Neurosurgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Roland Jabre
- Division of Neurosurgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
| | - Katrina H D Ignacio
- Calgary Stroke Program, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Foothills Medical Centre, Calgary, AB, Canada. https://twitter.com/Katha_MD
| | - Abdelsimar T Omar
- Division of Neurosurgery, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, McMaster University, Hamilton, ON, Canada. https://twitter.com/atomar_md
| | - David Volders
- Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
| | - Adam A Dmytriw
- Division of Diagnostic and Therapeutic Neuroradiology, Department of Radiology, St. Michael's Hospital, University of Toronto, ON, Canada; Neuroendovascular Program, Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. https://twitter.com/AdamDmytriw
| | - Jean-François Hak
- Department of Medical Imaging, University Hospital Timone APHM, Marseille, France. https://twitter.com/JFHak
| | - Géraud Forestier
- Department of neuroradiology, University Hospital of Limoges, Limoges, France. https://twitter.com/GeraudForestier
| | - Quentin Holay
- Department of Radiology, Sainte-Anne Military Hospital, Toulon, France
| | - Richard Olatunji
- Department of Radiology, College of Medicine, University of Ibadan, Ibadan, Nigeria. https://twitter.com/RICHARDOlat
| | - Ibrahim Alhabli
- Calgary Stroke Program, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Foothills Medical Centre, Calgary, AB, Canada. https://twitter.com/ialhabli
| | - Lorena Nico
- Department of Neuroradiology, University Hospital Of Padova, Padova, Italy
| | - Jai J S Shankar
- Department of Radiology, Health Sciences Centre, Winnipeg, MB, Canada. https://twitter.com/shivajai1
| | - Adrien Guenego
- Department of Interventional Neuroradiology, Erasme University Hospital, Brussels, Belgium. https://twitter.com/GuenegoAdrien
| | - Jose L R Pascual
- Department of Anatomy, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines. https://twitter.com/drbrainhacker
| | - Thomas R Marotta
- Division of Diagnostic and Therapeutic Neuroradiology, Department of Radiology, St. Michael's Hospital, University of Toronto, ON, Canada. https://twitter.com/trmarot
| | - Juan I Errázuriz
- Department of Radiology, McGill University Health Centre (MUHC), Montreal, QC, Canada
| | - Amy W Lin
- Division of Diagnostic and Therapeutic Neuroradiology, Department of Radiology, St. Michael's Hospital, University of Toronto, ON, Canada
| | - Aderaldo Costa Alves
- Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. https://twitter.com/jr_aderaldo
| | - Robert Fahed
- Division of Neurology, The Ottawa Hospital, Ottawa, ON, Canada
| | - Christine Hawkes
- Division of Neurology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. https://twitter.com/CMHawkes
| | - Hubert Lee
- Division of Neurosurgery, Trillium Health Partners, Toronto, ON, Canada
| | - Elsa Magro
- Department of Neurosurgery, Hôpital de la Cavale Blanche, CHRU de Brest, Brest, France
| | - Lila Sheikhi
- Department of Neurology, University of Kentucky, Lexington, KY, USA. https://twitter.com/lila_sheikhi
| | - Tim E Darsaut
- Department of Surgery, Division of Neurosurgery, Walter C. Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, AB, Canada. https://twitter.com/tdarsaut
| | - Jean Raymond
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
| |
Collapse
|
27
|
Rytky SJO, Tiulpin A, Finnilä MAJ, Karhula SS, Sipola A, Kurttila V, Valkealahti M, Lehenkari P, Joukainen A, Kröger H, Korhonen RK, Saarakkala S, Niinimäki J. Clinical Super-Resolution Computed Tomography of Bone Microstructure: Application in Musculoskeletal and Dental Imaging. Ann Biomed Eng 2024; 52:1255-1269. [PMID: 38361137 PMCID: PMC10995025 DOI: 10.1007/s10439-024-03450-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Accepted: 01/09/2024] [Indexed: 02/17/2024]
Abstract
PURPOSE Clinical cone-beam computed tomography (CBCT) devices are limited to imaging features of half a millimeter in size and cannot quantify the tissue microstructure. We demonstrate a robust deep-learning method for enhancing clinical CT images, only requiring a limited set of easy-to-acquire training data. METHODS Knee tissue from five cadavers and six total knee replacement patients, and 14 teeth from eight patients were scanned using laboratory CT as training data for the developed super-resolution (SR) technique. The method was benchmarked against ex vivo test set, 52 osteochondral samples are imaged with clinical and laboratory CT. A quality assurance phantom was imaged with clinical CT to quantify the technical image quality. To visually assess the clinical image quality, musculoskeletal and maxillofacial CBCT studies were enhanced with SR and contrasted to interpolated images. A dental radiologist and surgeon reviewed the maxillofacial images. RESULTS The SR models predicted the bone morphological parameters on the ex vivo test set more accurately than conventional image processing. The phantom analysis confirmed higher spatial resolution on the SR images than interpolation, but image grayscales were modified. Musculoskeletal and maxillofacial CBCT images showed more details on SR than interpolation; however, artifacts were observed near the crown of the teeth. The readers assessed mediocre overall scores for both SR and interpolation. The source code and pretrained networks are publicly available. CONCLUSION Model training with laboratory modalities could push the resolution limit beyond state-of-the-art clinical musculoskeletal and dental CBCT. A larger maxillofacial training dataset is recommended for dental applications.
Collapse
Affiliation(s)
- Santeri J O Rytky
- Research Unit of Health Sciences and Technology, University of Oulu, POB 5000, 90014, Oulu, Finland.
| | - Aleksei Tiulpin
- Research Unit of Health Sciences and Technology, University of Oulu, POB 5000, 90014, Oulu, Finland
- Neurocenter Oulu, Oulu University Hospital, Oulu, Finland
| | - Mikko A J Finnilä
- Research Unit of Health Sciences and Technology, University of Oulu, POB 5000, 90014, Oulu, Finland
- Medical Research Center, University of Oulu, Oulu, Finland
| | - Sakari S Karhula
- Research Unit of Health Sciences and Technology, University of Oulu, POB 5000, 90014, Oulu, Finland
- Department of Radiotherapy, Oulu University Hospital, Oulu, Finland
| | - Annina Sipola
- Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland
| | - Väinö Kurttila
- Department of Oral and Maxillofacial Surgery, Oulu University Hospital, Oulu, Finland
| | - Maarit Valkealahti
- Department of Surgery and Intensive Care, Oulu University Hospital, Oulu, Finland
| | - Petri Lehenkari
- Department of Surgery and Intensive Care, Oulu University Hospital, Oulu, Finland
- Cancer and Translational Medical Research Unit, Faculty of Medicine, University of Oulu, Oulu, Finland
| | - Antti Joukainen
- Department of Orthopaedics, Traumatology and Hand Surgery, Kuopio University Hospital, Kuopio, Finland
| | - Heikki Kröger
- Department of Orthopaedics, Traumatology and Hand Surgery, Kuopio University Hospital, Kuopio, Finland
| | - Rami K Korhonen
- Department of Applied Physics, University of Eastern Finland, Kuopio, Finland
| | - Simo Saarakkala
- Research Unit of Health Sciences and Technology, University of Oulu, POB 5000, 90014, Oulu, Finland
- Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland
| | - Jaakko Niinimäki
- Research Unit of Health Sciences and Technology, University of Oulu, POB 5000, 90014, Oulu, Finland
- Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland
| |
Collapse
|
28
|
Brady AP, Allen B, Chong J, Kotter E, Kottler N, Mongan J, Oakden-Rayner L, Dos Santos DP, Tang A, Wald C, Slavotinek J. Developing, Purchasing, Implementing and Monitoring AI Tools in Radiology: Practical Considerations. A Multi-Society Statement From the ACR, CAR, ESR, RANZCR & RSNA. Can Assoc Radiol J 2024; 75:226-244. [PMID: 38251882 DOI: 10.1177/08465371231222229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2024] Open
Abstract
Artificial Intelligence (AI) carries the potential for unprecedented disruption in radiology, with possible positive and negative consequences. The integration of AI in radiology holds the potential to revolutionize healthcare practices by advancing diagnosis, quantification, and management of multiple medical conditions. Nevertheless, the ever‑growing availability of AI tools in radiology highlights an increasing need to critically evaluate claims for its utility and to differentiate safe product offerings from potentially harmful, or fundamentally unhelpful ones. This multi‑society paper, presenting the views of Radiology Societies in the USA, Canada, Europe, Australia, and New Zealand, defines the potential practical problems and ethical issues surrounding the incorporation of AI into radiological practice. In addition to delineating the main points of concern that developers, regulators, and purchasers of AI tools should consider prior to their introduction into clinical practice, this statement also suggests methods to monitor their stability and safety in clinical use, and their suitability for possible autonomous function. This statement is intended to serve as a useful summary of the practical issues which should be considered by all parties involved in the development of radiology AI resources, and their implementation as clinical tools.
Collapse
Affiliation(s)
| | - Bibb Allen
- Department of Radiology, Grandview Medical Center, Birmingham, AL, USA
- Data Science Institute, American College of Radiology, Reston, VA, USA
| | - Jaron Chong
- Department of Medical Imaging, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
| | - Elmar Kotter
- Department of Diagnostic and Interventional Radiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Nina Kottler
- Radiology Partners, El Segundo, CA, USA
- Stanford Center for Artificial Intelligence in Medicine & Imaging, Palo Alto, CA, USA
| | - John Mongan
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA
| | - Lauren Oakden-Rayner
- Australian Institute for Machine Learning, University of Adelaide, Adelaide, SA, Australia
| | - Daniel Pinto Dos Santos
- Department of Radiology, University Hospital of Cologne, Cologne, Germany
- Department of Radiology, University Hospital of Frankfurt, Frankfurt, Germany
| | - An Tang
- Department of Radiology, Radiation Oncology, and Nuclear Medicine, Université de Montréal, Montréal, QC, Canada
| | - Christoph Wald
- Department of Radiology, Lahey Hospital & Medical Center, Burlington, MA, USA
- Tufts University Medical School, Boston, MA, USA
- American College of Radiology, Reston, VA, USA
| | - John Slavotinek
- South Australia Medical Imaging, Flinders Medical Centre Adelaide, SA, Australia
- College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia
| |
Collapse
|
29
|
Hu B, Shi Z, Lu L, Miao Z, Wang H, Zhou Z, Zhang F, Wang R, Luo X, Xu F, Li S, Fang X, Wang X, Yan G, Lv F, Zhang M, Sun Q, Cui G, Liu Y, Zhang S, Pan C, Hou Z, Liang H, Pan Y, Chen X, Li X, Zhou F, Schoepf UJ, Varga-Szemes A, Garrison Moore W, Yu Y, Hu C, Zhang LJ, China Aneurysm AI Project Group. A deep-learning model for intracranial aneurysm detection on CT angiography images in China: a stepwise, multicentre, early-stage clinical validation study. Lancet Digit Health 2024; 6:e261-e271. [PMID: 38519154 DOI: 10.1016/s2589-7500(23)00268-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Collaborators] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Revised: 10/23/2023] [Accepted: 12/29/2023] [Indexed: 03/24/2024]
Abstract
BACKGROUND Artificial intelligence (AI) models in real-world implementation are scarce. Our study aimed to develop a CT angiography (CTA)-based AI model for intracranial aneurysm detection, assess how it helps clinicians improve diagnostic performance, and validate its application in real-world clinical implementation. METHODS We developed a deep-learning model using 16 546 head and neck CTA examination images from 14 517 patients at eight Chinese hospitals. Using an adapted, stepwise implementation and evaluation, 120 certified clinicians from 15 geographically different hospitals were recruited. Initially, the AI model was externally validated with images of 900 digital subtraction angiography-verified CTA cases (examinations) and compared with the performance of 24 clinicians who each viewed 300 of these cases (stage 1). Next, as a further external validation a multi-reader multi-case study enrolled 48 clinicians to individually review 298 digital subtraction angiography-verified CTA cases (stage 2). The clinicians reviewed each CTA examination twice (ie, with and without the AI model), separated by a 4-week washout period. Then, a randomised open-label comparison study enrolled 48 clinicians to assess the acceptance and performance of this AI model (stage 3). Finally, the model was prospectively deployed and validated in 1562 real-world clinical CTA cases. FINDINGS The AI model in the internal dataset achieved a patient-level diagnostic sensitivity of 0·957 (95% CI 0·939-0·971) and a higher patient-level diagnostic sensitivity than clinicians (0·943 [0·921-0·961] vs 0·658 [0·644-0·672]; p<0·0001) in the external dataset. In the multi-reader multi-case study, the AI-assisted strategy improved clinicians' diagnostic performance both on a per-patient basis (the area under the receiver operating characteristic curves [AUCs]; 0·795 [0·761-0·830] without AI vs 0·878 [0·850-0·906] with AI; p<0·0001) and a per-aneurysm basis (the area under the weighted alternative free-response receiver operating characteristic curves; 0·765 [0·732-0·799] vs 0·865 [0·839-0·891]; p<0·0001). Reading time decreased with the aid of the AI model (87·5 s vs 82·7 s, p<0·0001). In the randomised open-label comparison study, clinicians in the AI-assisted group had a high acceptance of the AI model (92·6% adoption rate), and a higher AUC when compared with the control group (0·858 [95% CI 0·850-0·866] vs 0·789 [0·780-0·799]; p<0·0001). In the prospective study, the AI model had a 0·51% (8/1570) error rate due to poor-quality CTA images and recognition failure. The model had a high negative predictive value of 0·998 (0·994-1·000) and significantly improved the diagnostic performance of clinicians; AUC improved from 0·787 (95% CI 0·766-0·808) to 0·909 (0·894-0·923; p<0·0001) and patient-level sensitivity improved from 0·590 (0·511-0·666) to 0·825 (0·759-0·880; p<0·0001). INTERPRETATION This AI model demonstrated strong clinical potential for intracranial aneurysm detection with improved clinician diagnostic performance, high acceptance, and practical implementation in real-world clinical cases. FUNDING National Natural Science Foundation of China. TRANSLATION For the Chinese translation of the abstract see Supplementary Materials section.
Collapse
Affiliation(s)
- Bin Hu
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
| | - Zhao Shi
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
| | - Li Lu
- Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - Zhongchang Miao
- Department of Medical Imaging, the First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China
| | - Hao Wang
- Deepwise Artificial Intelligence (AI) Lab, Deepwise, Beijing, China
| | - Zhen Zhou
- Deepwise Artificial Intelligence (AI) Lab, Deepwise, Beijing, China
| | - Fandong Zhang
- Deepwise Artificial Intelligence (AI) Lab, Deepwise, Beijing, China
| | - Rongpin Wang
- Department of Medical Imaging, Guizhou Province People's Hospital, Guiyang, Guizhou, China
| | - Xiao Luo
- Department of Radiology, Ma'anshan People's Hospital, Ma'anshan, Anhui, China
| | - Feng Xu
- Department of Medical Imaging, the Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu, China
| | - Sheng Li
- Department of Radiology, People's Hospital, Hubei University of Medicine, Shiyan, Hubei, China
| | - Xiangming Fang
- Department of Medical Imaging, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China
| | - Xiaodong Wang
- Department of Radiology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China
| | - Ge Yan
- Department of Medical Imaging, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
| | - Fajin Lv
- Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Meng Zhang
- Department of Radiology, People's Hospital of Sanya, Sanya, Hainan, China
| | - Qiu Sun
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | - Guangbin Cui
- Department of Radiology, Tangdu Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, Shaanxi, China
| | - Yubao Liu
- Medical Imaging Center, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China
| | - Shu Zhang
- Deepwise Artificial Intelligence (AI) Lab, Deepwise, Beijing, China
| | - Chengwei Pan
- Institute of Artificial Intelligence, Beihang University, Beijing, China
| | - Zhibo Hou
- Department of Radiology, Medical Imaging Center, Peking University Shougang Hospital, Beijing, China
| | - Huiying Liang
- Medical Big Data Center, Guangdong Provincial People's Hospital, Guangzhou Guangdong, China
| | - Yuning Pan
- Department of Radiology, Ningbo First Hospital, Ningbo, Zhejiang, China
| | - Xiaoxia Chen
- Department of Radiology, Third Center Medical Center, Chinese PLA General Hospital, Beijing, China
| | - Xiaorong Li
- Department of Radiology, General Hospital of Southern Theater Command, PLA, Guangzhou, Guangdong, China
| | - Fei Zhou
- Department of Radiology, Central Hospital of Jilin City, Jilin, China
| | - U Joseph Schoepf
- Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA
| | - Akos Varga-Szemes
- Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA
| | - W Garrison Moore
- Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA
| | - Yizhou Yu
- Department of Computer Science, The University of Hong Kong, Hong Kong Special Administrative Region, China
| | - Chunfeng Hu
- Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
| | - Long Jiang Zhang
- Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
| | | |
Collapse
Collaborators
Bin Hu, Zhao Shi, Li Lu, Zhongchang Miao, Hao Wang, Zhen Zhou, Fandong Zhang, Rongpin Wang, Xiao Luo, Feng Xu, Sheng Li, Xiangming Fang, Xiaodong Wang, Ge Yan, Fajin Lv, Meng Zhang, Qiu Sun, Guangbin Cui, Yubao Liu, Shu Zhang, Chengwei Pan, Zhibo Hou, Huiying Liang, Yuning Pan, Xiaoxia Chen, Xiaorong Li, Fei Zhou, Bin Tan, Feidi Liu, Feng Chen, Hongmei Gu, Mingli Hou, Rui Xu, Rui Zuo, Shumin Tao, Weiwei Chen, Xue Chai, Wulin Wang, Yongjian Dai, Yueqin Chen, Changsheng Zhou, Guang Ming Lu, U Joseph Schoepf, W Garrison Moore, Akos Varga-Szemes, Yizhou Yu, Chunfeng Hu, Longjiang Zhang,
Collapse
|
30
|
Shao J, Lin H, Ding L, Li B, Xu D, Sun Y, Guan T, Dai H, Liu R, Deng D, Huang B, Feng S, Diao X, Gao Z. Deep learning for differentiation of osteolytic osteosarcoma and giant cell tumor around the knee joint on radiographs: a multicenter study. Insights Imaging 2024; 15:35. [PMID: 38321327 PMCID: PMC10847082 DOI: 10.1186/s13244-024-01610-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 12/21/2023] [Indexed: 02/08/2024] Open
Abstract
OBJECTIVES To develop a deep learning (DL) model for differentiating between osteolytic osteosarcoma (OS) and giant cell tumor (GCT) on radiographs. METHODS Patients with osteolytic OS and GCT proven by postoperative pathology were retrospectively recruited from four centers (center A, training and internal testing; centers B, C, and D, external testing). Sixteen radiologists with different experiences in musculoskeletal imaging diagnosis were divided into three groups and participated with or without the DL model's assistance. DL model was generated using EfficientNet-B6 architecture, and the clinical model was trained using clinical variables. The performance of various models was compared using McNemar's test. RESULTS Three hundred thirty-three patients were included (mean age, 27 years ± 12 [SD]; 186 men). Compared to the clinical model, the DL model achieved a higher area under the curve (AUC) in both the internal (0.97 vs. 0.77, p = 0.008) and external test set (0.97 vs. 0.64, p < 0.001). In the total test set (including the internal and external test sets), the DL model achieved higher accuracy than the junior expert committee (93.1% vs. 72.4%; p < 0.001) and was comparable to the intermediate and senior expert committee (93.1% vs. 88.8%, p = 0.25; 87.1%, p = 0.35). With DL model assistance, the accuracy of the junior expert committee was improved from 72.4% to 91.4% (p = 0.051). CONCLUSION The DL model accurately distinguished osteolytic OS and GCT with better performance than the junior radiologists, whose own diagnostic performances were significantly improved with the aid of the model, indicating the potential for the differential diagnosis of the two bone tumors on radiographs. CRITICAL RELEVANCE STATEMENT The deep learning model can accurately distinguish osteolytic osteosarcoma and giant cell tumor on radiographs, which may help radiologists improve the diagnostic accuracy of two types of tumors. KEY POINTS • The DL model shows robust performance in distinguishing osteolytic osteosarcoma and giant cell tumor. • The diagnosis performance of the DL model is better than junior radiologists'. • The DL model shows potential for differentiating osteolytic osteosarcoma and giant cell tumor.
Collapse
Affiliation(s)
- Jingjing Shao
- Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
| | - Hongxin Lin
- Medical AI Lab, School of Biomedical Engineering, Health Science Centre, Shenzhen University, Shenzhen, Guangdong, China
| | - Lei Ding
- Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
| | - Bing Li
- Medical AI Lab, School of Biomedical Engineering, Health Science Centre, Shenzhen University, Shenzhen, Guangdong, China
| | - Danyang Xu
- Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
| | - Yang Sun
- Department of Radiology, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong, China
| | - Tianming Guan
- Department of Radiology, Hui Ya Hospital of The First Affiliated Hospital, Sun Yat-Sen University, Huizhou, Guangdong, China
| | - Haiyang Dai
- Department of Radiology, People's Hospital of Huizhou City Center, Huizhou, Guangdong, China
| | - Ruihao Liu
- Medical AI Lab, School of Biomedical Engineering, Health Science Centre, Shenzhen University, Shenzhen, Guangdong, China
| | - Demao Deng
- Department of Radiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Guanxi Academy of Medical Science, Nanning, Guangxi, China
| | - Bingsheng Huang
- Medical AI Lab, School of Biomedical Engineering, Health Science Centre, Shenzhen University, Shenzhen, Guangdong, China
| | - Shiting Feng
- Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
| | - Xianfen Diao
- National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Medicine, Shenzhen University, Shenzhen, Guangdong, China.
| | - Zhenhua Gao
- Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Department of Radiology, Hui Ya Hospital of The First Affiliated Hospital, Sun Yat-Sen University, Huizhou, Guangdong, China.
| |
Collapse
|
31
|
Brady AP, Allen B, Chong J, Kotter E, Kottler N, Mongan J, Oakden-Rayner L, Pinto Dos Santos D, Tang A, Wald C, Slavotinek J. Developing, purchasing, implementing and monitoring AI tools in radiology: Practical considerations. A multi-society statement from the ACR, CAR, ESR, RANZCR & RSNA. J Med Imaging Radiat Oncol 2024; 68:7-26. [PMID: 38259140 DOI: 10.1111/1754-9485.13612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Accepted: 11/23/2023] [Indexed: 01/24/2024]
Abstract
Artificial Intelligence (AI) carries the potential for unprecedented disruption in radiology, with possible positive and negative consequences. The integration of AI in radiology holds the potential to revolutionize healthcare practices by advancing diagnosis, quantification, and management of multiple medical conditions. Nevertheless, the ever-growing availability of AI tools in radiology highlights an increasing need to critically evaluate claims for its utility and to differentiate safe product offerings from potentially harmful, or fundamentally unhelpful ones. This multi-society paper, presenting the views of Radiology Societies in the USA, Canada, Europe, Australia, and New Zealand, defines the potential practical problems and ethical issues surrounding the incorporation of AI into radiological practice. In addition to delineating the main points of concern that developers, regulators, and purchasers of AI tools should consider prior to their introduction into clinical practice, this statement also suggests methods to monitor their stability and safety in clinical use, and their suitability for possible autonomous function. This statement is intended to serve as a useful summary of the practical issues which should be considered by all parties involved in the development of radiology AI resources, and their implementation as clinical tools.
Collapse
Affiliation(s)
| | - Bibb Allen
- Department of Radiology, Grandview Medical Center, Birmingham, Alabama, USA
- American College of Radiology Data Science Institute, Reston, Virginia, USA
| | - Jaron Chong
- Department of Medical Imaging, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada
| | - Elmar Kotter
- Department of Diagnostic and Interventional Radiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Nina Kottler
- Radiology Partners, El Segundo, California, USA
- Stanford Center for Artificial Intelligence in Medicine & Imaging, Palo Alto, California, USA
| | - John Mongan
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA
| | - Lauren Oakden-Rayner
- Australian Institute for Machine Learning, University of Adelaide, Adelaide, South Australia, Australia
| | - Daniel Pinto Dos Santos
- Department of Radiology, University Hospital of Cologne, Cologne, Germany
- Department of Radiology, University Hospital of Frankfurt, Frankfurt, Germany
| | - An Tang
- Department of Radiology, Radiation Oncology, and Nuclear Medicine, Université de Montréal, Montreal, Quebec, Canada
| | - Christoph Wald
- Department of Radiology, Lahey Hospital & Medical Center, Burlington, Massachusetts, USA
- Tufts University Medical School, Boston, Massachusetts, USA
- Commision On Informatics, and Member, Board of Chancellors, American College of Radiology, Reston, Virginia, USA
| | - John Slavotinek
- South Australia Medical Imaging, Flinders Medical Centre Adelaide, Adelaide, South Australia, Australia
- College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia
| |
Collapse
|
32
|
De Luca F, Kits A, Martin Muñoz D, Aspelin Å, Kvist O, Österman Y, Diaz Ruiz S, Skare S, Falk Delgado A. Elective one-minute full brain multi-contrast MRI versus brain CT in pediatric patients: a prospective feasibility study. BMC Med Imaging 2024; 24:23. [PMID: 38267889 PMCID: PMC10809606 DOI: 10.1186/s12880-024-01196-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Accepted: 01/08/2024] [Indexed: 01/26/2024] Open
Abstract
BACKGROUND Brain CT can be used to evaluate pediatric patients with suspicion of cerebral pathology when anesthetic and MRI resources are scarce. This study aimed to assess if pediatric patients referred for an elective brain CT could endure a diagnostic fast brain MRI without general anesthesia using a one-minute multi-contrast EPI-based sequence (EPIMix) with comparable diagnostic performance. METHODS Pediatric patients referred for an elective brain CT between March 2019 and March 2020 were prospectively included and underwent EPIMix without general anesthesia in addition to CT. Three readers (R1-3) independently evaluated EPIMix and CT images on two separate occasions. The two main study outcomes were the tolerance to undergo an EPIMix scan without general anesthesia and its performance to classify a scan as normal or abnormal. Secondary outcomes were assessment of disease category, incidental findings, diagnostic image quality, diagnostic confidence, and image artifacts. Further, a side-by-side evaluation of EPIMix and CT was performed. The signal-to-noise ratio (SNR) was calculated for EPIMix on T1-weighted, T2-weighted, and ADC images. Descriptive statistics, Fisher's exact test, and Chi-squared test were used to compare the two imaging modalities. RESULTS EPIMix was well tolerated by all included patients (n = 15) aged 5-16 (mean 11, SD 3) years old. Thirteen cases on EPIMix and twelve cases on CT were classified as normal by all readers (R1-3), while two cases on EPIMix and three cases on CT were classified as abnormal by one reader (R1), (R1-3, p = 1.00). There was no evidence of a difference in diagnostic confidence, image quality, or the presence of motion artifacts between EPIMix and CT (R1-3, p ≥ 0.10). Side-by-side evaluation (R2 + R4 + R5) reviewed all scans as lacking significant pathological findings on EPIMix and CT images. CONCLUSIONS Full brain MRI-based EPIMix sequence was well tolerated without general anesthesia with a diagnostic performance comparable to CT in elective pediatric patients. TRIAL REGISTRATION This study was approved by the Swedish Ethical Review Authority (ethical approval number/ID Ethical approval 2017/2424-31/1). This study was a clinical trial study, with study protocol published at ClinicalTrials.gov with Trial registration number NCT03847051, date of registration 18/02/2019.
Collapse
Affiliation(s)
- Francesca De Luca
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
- Department of Radiology, Karolinska University Hospital, Stockholm, Sweden.
| | - Annika Kits
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
- Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - Daniel Martin Muñoz
- Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - Åsa Aspelin
- Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - Ola Kvist
- Department of Pediatric Radiology, Karolinska University Hospital, Stockholm, Sweden
- Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden
| | - Yords Österman
- Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - Sandra Diaz Ruiz
- Department of Pediatric Radiology, Karolinska University Hospital, Stockholm, Sweden
- Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden
- Department of Radiology, Lund University, Lund, Sweden
| | - Stefan Skare
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
- Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - Anna Falk Delgado
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
- Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| |
Collapse
|
33
|
Brady AP, Allen B, Chong J, Kotter E, Kottler N, Mongan J, Oakden-Rayner L, Dos Santos DP, Tang A, Wald C, Slavotinek J. Developing, purchasing, implementing and monitoring AI tools in radiology: practical considerations. A multi-society statement from the ACR, CAR, ESR, RANZCR & RSNA. Insights Imaging 2024; 15:16. [PMID: 38246898 PMCID: PMC10800328 DOI: 10.1186/s13244-023-01541-3] [Citation(s) in RCA: 25] [Impact Index Per Article: 25.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2024] Open
Abstract
Artificial Intelligence (AI) carries the potential for unprecedented disruption in radiology, with possible positive and negative consequences. The integration of AI in radiology holds the potential to revolutionize healthcare practices by advancing diagnosis, quantification, and management of multiple medical conditions. Nevertheless, the ever-growing availability of AI tools in radiology highlights an increasing need to critically evaluate claims for its utility and to differentiate safe product offerings from potentially harmful, or fundamentally unhelpful ones.This multi-society paper, presenting the views of Radiology Societies in the USA, Canada, Europe, Australia, and New Zealand, defines the potential practical problems and ethical issues surrounding the incorporation of AI into radiological practice. In addition to delineating the main points of concern that developers, regulators, and purchasers of AI tools should consider prior to their introduction into clinical practice, this statement also suggests methods to monitor their stability and safety in clinical use, and their suitability for possible autonomous function. This statement is intended to serve as a useful summary of the practical issues which should be considered by all parties involved in the development of radiology AI resources, and their implementation as clinical tools.Key points • The incorporation of artificial intelligence (AI) in radiological practice demands increased monitoring of its utility and safety.• Cooperation between developers, clinicians, and regulators will allow all involved to address ethical issues and monitor AI performance.• AI can fulfil its promise to advance patient well-being if all steps from development to integration in healthcare are rigorously evaluated.
Collapse
Affiliation(s)
| | - Bibb Allen
- Department of Radiology, Grandview Medical Center, Birmingham, AL, USA
- American College of Radiology Data Science Institute, Reston, VA, USA
| | - Jaron Chong
- Department of Medical Imaging, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
| | - Elmar Kotter
- Department of Diagnostic and Interventional Radiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Nina Kottler
- Radiology Partners, El Segundo, CA, USA
- Stanford Center for Artificial Intelligence in Medicine & Imaging, Palo Alto, CA, USA
| | - John Mongan
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, USA
| | - Lauren Oakden-Rayner
- Australian Institute for Machine Learning, University of Adelaide, Adelaide, Australia
| | - Daniel Pinto Dos Santos
- Department of Radiology, University Hospital of Cologne, Cologne, Germany
- Department of Radiology, University Hospital of Frankfurt, Frankfurt, Germany
| | - An Tang
- Department of Radiology, Radiation Oncology, and Nuclear Medicine, Université de Montréal, Montréal, Québec, Canada
| | - Christoph Wald
- Department of Radiology, Lahey Hospital & Medical Center, Burlington, MA, USA
- Tufts University Medical School, Boston, MA, USA
- Commision On Informatics, and Member, Board of Chancellors, American College of Radiology, Virginia, USA
| | - John Slavotinek
- South Australia Medical Imaging, Flinders Medical Centre Adelaide, Adelaide, Australia
- College of Medicine and Public Health, Flinders University, Adelaide, Australia
| |
Collapse
|
34
|
Frood R, Willaime JMY, Miles B, Chambers G, Al-Chalabi H, Ali T, Hougham N, Brooks N, Petrides G, Naylor M, Ward D, Sulkin T, Chaytor R, Strouhal P, Patel C, Scarsbrook AF. Comparative effectiveness of standard vs. AI-assisted PET/CT reading workflow for pre-treatment lymphoma staging: a multi-institutional reader study evaluation. FRONTIERS IN NUCLEAR MEDICINE (LAUSANNE, SWITZERLAND) 2024; 3:1327186. [PMID: 39355039 PMCID: PMC11440880 DOI: 10.3389/fnume.2023.1327186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Accepted: 12/27/2023] [Indexed: 10/03/2024]
Abstract
Background Fluorine-18 fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) is widely used for staging high-grade lymphoma, with the time to evaluate such studies varying depending on the complexity of the case. Integrating artificial intelligence (AI) within the reporting workflow has the potential to improve quality and efficiency. The aims of the present study were to evaluate the influence of an integrated research prototype segmentation tool implemented within diagnostic PET/CT reading software on the speed and quality of reporting with variable levels of experience, and to assess the effect of the AI-assisted workflow on reader confidence and whether this tool influenced reporting behaviour. Methods Nine blinded reporters (three trainees, three junior consultants and three senior consultants) from three UK centres participated in a two-part reader study. A total of 15 lymphoma staging PET/CT scans were evaluated twice: first, using a standard PET/CT reporting workflow; then, after a 6-week gap, with AI assistance incorporating pre-segmentation of disease sites within the reading software. An even split of PET/CT segmentations with gold standard (GS), false-positive (FP) over-contour or false-negative (FN) under-contour were provided. The read duration was calculated using file logs, while the report quality was independently assessed by two radiologists with >15 years of experience. Confidence in AI assistance and identification of disease was assessed via online questionnaires for each case. Results There was a significant decrease in time between non-AI and AI-assisted reads (median 15.0 vs. 13.3 min, p < 0.001). Sub-analysis confirmed this was true for both junior (14.5 vs. 12.7 min, p = 0.03) and senior consultants (15.1 vs. 12.2 min, p = 0.03) but not for trainees (18.1 vs. 18.0 min, p = 0.2). There was no significant difference between report quality between reads. AI assistance provided a significant increase in confidence of disease identification (p < 0.001). This held true when splitting the data into FN, GS and FP. In 19/88 cases, participants did not identify either FP (31.8%) or FN (11.4%) segmentations. This was significantly greater for trainees (13/30, 43.3%) than for junior (3/28, 10.7%, p = 0.05) and senior consultants (3/30, 10.0%, p = 0.05). Conclusions The study findings indicate that an AI-assisted workflow achieves comparable performance to humans, demonstrating a marginal enhancement in reporting speed. Less experienced readers were more influenced by segmentation errors. An AI-assisted PET/CT reading workflow has the potential to increase reporting efficiency without adversely affecting quality, which could reduce costs and report turnaround times. These preliminary findings need to be confirmed in larger studies.
Collapse
Affiliation(s)
- Russell Frood
- Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
- Leeds Institute of Health Research, University of Leeds, Leeds, United Kingdom
| | | | - Brad Miles
- Alliance Medical Ltd., Warwick, United Kingdom
| | - Greg Chambers
- Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
| | - H’ssein Al-Chalabi
- Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
- Department of Radiology, York and Scarborough Teaching Hospitals NHS Foundation Trust, York, United Kingdom
| | - Tamir Ali
- Department of Radiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
| | - Natasha Hougham
- Department of Radiology, Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom
| | | | - George Petrides
- Department of Radiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
| | - Matthew Naylor
- Department of Radiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
| | - Daniel Ward
- Department of Radiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
| | - Tom Sulkin
- Department of Radiology, Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom
| | - Richard Chaytor
- Department of Radiology, Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom
| | | | - Chirag Patel
- Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
| | - Andrew F. Scarsbrook
- Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
- Leeds Institute of Health Research, University of Leeds, Leeds, United Kingdom
| |
Collapse
|
35
|
Brady AP, Allen B, Chong J, Kotter E, Kottler N, Mongan J, Oakden-Rayner L, dos Santos DP, Tang A, Wald C, Slavotinek J. Developing, Purchasing, Implementing and Monitoring AI Tools in Radiology: Practical Considerations. A Multi-Society Statement from the ACR, CAR, ESR, RANZCR and RSNA. Radiol Artif Intell 2024; 6:e230513. [PMID: 38251899 PMCID: PMC10831521 DOI: 10.1148/ryai.230513] [Citation(s) in RCA: 15] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2024]
Abstract
Artificial Intelligence (AI) carries the potential for unprecedented disruption in radiology, with possible positive and negative consequences. The integration of AI in radiology holds the potential to revolutionize healthcare practices by advancing diagnosis, quantification, and management of multiple medical conditions. Nevertheless, the ever-growing availability of AI tools in radiology highlights an increasing need to critically evaluate claims for its utility and to differentiate safe product offerings from potentially harmful, or fundamentally unhelpful ones. This multi-society paper, presenting the views of Radiology Societies in the USA, Canada, Europe, Australia, and New Zealand, defines the potential practical problems and ethical issues surrounding the incorporation of AI into radiological practice. In addition to delineating the main points of concern that developers, regulators, and purchasers of AI tools should consider prior to their introduction into clinical practice, this statement also suggests methods to monitor their stability and safety in clinical use, and their suitability for possible autonomous function. This statement is intended to serve as a useful summary of the practical issues which should be considered by all parties involved in the development of radiology AI resources, and their implementation as clinical tools. This article is simultaneously published in Insights into Imaging (DOI 10.1186/s13244-023-01541-3), Journal of Medical Imaging and Radiation Oncology (DOI 10.1111/1754-9485.13612), Canadian Association of Radiologists Journal (DOI 10.1177/08465371231222229), Journal of the American College of Radiology (DOI 10.1016/j.jacr.2023.12.005), and Radiology: Artificial Intelligence (DOI 10.1148/ryai.230513). Keywords: Artificial Intelligence, Radiology, Automation, Machine Learning Published under a CC BY 4.0 license. ©The Author(s) 2024. Editor's Note: The RSNA Board of Directors has endorsed this article. It has not undergone review or editing by this journal.
Collapse
Affiliation(s)
| | - Bibb Allen
- Department of Radiology, Grandview Medical
Center, Birmingham, AL, USA
- American College of Radiology Data Science
Institute, Reston, VA, USA
| | - Jaron Chong
- Department of Medical Imaging, Schulich
School of Medicine and Dentistry, Western University, London, ON, Canada
| | - Elmar Kotter
- Department of Diagnostic and
Interventional Radiology, Medical Center, Faculty of Medicine, University of
Freiburg, Freiburg, Germany
| | - Nina Kottler
- Radiology Partners, El Segundo, CA,
USA
- Stanford Center for Artificial
Intelligence in Medicine & Imaging, Palo Alto, CA, USA
| | - John Mongan
- Department of Radiology and Biomedical
Imaging, University of California, San Francisco, USA
| | - Lauren Oakden-Rayner
- Australian Institute for Machine Learning,
University of Adelaide, Adelaide, Australia
| | - Daniel Pinto dos Santos
- Department of Radiology, University
Hospital of Cologne, Cologne, Germany
- Department of Radiology, University
Hospital of Frankfurt, Frankfurt, Germany
| | - An Tang
- Department of Radiology, Radiation
Oncology, and Nuclear Medicine, Université de Montréal,
Montréal, Québec, Canada
| | - Christoph Wald
- Department of Radiology, Lahey Hospital
& Medical Center, Burlington, MA, USA
- Tufts University Medical School, Boston,
MA, USA
- Commission On Informatics, and Member,
Board of Chancellors, American College of Radiology, Virginia, USA
| | - John Slavotinek
- South Australia Medical Imaging,
Flinders Medical Centre Adelaide, Adelaide, Australia
- College of Medicine and Public Health,
Flinders University, Adelaide, Australia
| |
Collapse
|
36
|
Bachmann R, Gunes G, Hangaard S, Nexmann A, Lisouski P, Boesen M, Lundemann M, Baginski SG. Improving traumatic fracture detection on radiographs with artificial intelligence support: a multi-reader study. BJR Open 2024; 6:tzae011. [PMID: 38757067 PMCID: PMC11096271 DOI: 10.1093/bjro/tzae011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 10/13/2023] [Accepted: 04/21/2024] [Indexed: 05/18/2024] Open
Abstract
Objectives The aim of this study was to evaluate the diagnostic performance of nonspecialist readers with and without the use of an artificial intelligence (AI) support tool to detect traumatic fractures on radiographs of the appendicular skeleton. Methods The design was a retrospective, fully crossed multi-reader, multi-case study on a balanced dataset of patients (≥2 years of age) with an AI tool as a diagnostic intervention. Fifteen readers assessed 340 radiographic exams, with and without the AI tool in 2 different sessions and the time spent was automatically recorded. Reference standard was established by 3 consultant radiologists. Sensitivity, specificity, and false positives per patient were calculated. Results Patient-wise sensitivity increased from 72% to 80% (P < .05) and patient-wise specificity increased from 81% to 85% (P < .05) in exams aided by the AI tool compared to the unaided exams. The increase in sensitivity resulted in a relative reduction of missed fractures of 29%. The average rate of false positives per patient decreased from 0.16 to 0.14, corresponding to a relative reduction of 21%. There was no significant difference in average reading time spent per exam. The largest gain in fracture detection performance, with AI support, across all readers, was on nonobvious fractures with a significant increase in sensitivity of 11 percentage points (pp) (60%-71%). Conclusions The diagnostic performance for detection of traumatic fractures on radiographs of the appendicular skeleton improved among nonspecialist readers tested AI fracture detection support tool showed an overall reader improvement in sensitivity and specificity when supported by an AI tool. Improvement was seen in both sensitivity and specificity without negatively affecting the interpretation time. Advances in knowledge The division and analysis of obvious and nonobvious fractures are novel in AI reader comparison studies like this.
Collapse
Affiliation(s)
| | | | - Stine Hangaard
- Department of Radiology, Herlev and Gentofte, Copenhagen University Hospital, Denmark
| | | | | | - Mikael Boesen
- Department of Radiology and Radiological AI Testcenter (RAIT) Denmark, Bispebjerg and Frederiksberg, Copenhagen University Hospital, Denmark
- Department of Clinical Medicine, Faculty of Health, and Medical Sciences, University of Copenhagen, Denmark
| | | | | |
Collapse
|
37
|
Homssi M, Sweeney EM, Demmon E, Mannheim W, Sakirsky M, Wang Y, Gauthier SA, Gupta A, Nguyen TD. Evaluation of the Statistical Detection of Change Algorithm for Screening Patients with MS with New Lesion Activity on Longitudinal Brain MRI. AJNR Am J Neuroradiol 2023; 44:649-655. [PMID: 37142431 PMCID: PMC10249703 DOI: 10.3174/ajnr.a7858] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 04/03/2023] [Indexed: 05/06/2023]
Abstract
BACKGROUND AND PURPOSE Identification of new MS lesions on longitudinal MR imaging by human readers is time-consuming and prone to error. Our objective was to evaluate the improvement in the performance of subject-level detection by readers when assisted by the automated statistical detection of change algorithm. MATERIALS AND METHODS A total of 200 patients with MS with a mean interscan interval of 13.2 (SD, 2.4) months were included. Statistical detection of change was applied to the baseline and follow-up FLAIR images to detect potential new lesions for confirmation by readers (Reader + statistical detection of change method). This method was compared with readers operating in the clinical workflow (Reader method) for a subject-level detection of new lesions. RESULTS Reader + statistical detection of change found 30 subjects (15.0%) with at least 1 new lesion, while Reader detected 16 subjects (8.0%). As a subject-level screening tool, statistical detection of change achieved a perfect sensitivity of 1.00 (95% CI, 0.88-1.00) and a moderate specificity of 0.67 (95% CI, 0.59-0.74). The agreement on a subject level was 0.91 (95% CI, 0.87-0.95) between Reader + statistical detection of change and Reader, and 0.72 (95% CI, 0.66-0.78) between Reader + statistical detection of change and statistical detection of change. CONCLUSIONS The statistical detection of change algorithm can serve as a time-saving screening tool to assist human readers in verifying 3D FLAIR images of patients with MS with suspected new lesions. Our promising results warrant further evaluation of statistical detection of change in prospective multireader clinical studies.
Collapse
Affiliation(s)
- M Homssi
- From the Department of Radiology (M.H., Y.W., A.G., T.D.N.)
| | - E M Sweeney
- Penn Statistics in Imaging and Visualization Endeavor (PennSIVE) Center, Department of Biostatistics, Epidemiology, and Informatics (E.M.S.), University of Pennsylvania, Philadelphia, Pennsylvania
| | - E Demmon
- Department of Neurology (E.D., W.M., M.S., S.A.G.)
| | - W Mannheim
- Department of Neurology (E.D., W.M., M.S., S.A.G.)
| | - M Sakirsky
- Department of Neurology (E.D., W.M., M.S., S.A.G.)
| | - Y Wang
- From the Department of Radiology (M.H., Y.W., A.G., T.D.N.)
| | - S A Gauthier
- Department of Neurology (E.D., W.M., M.S., S.A.G.)
- The Feil Family Brain & Mind Institute (S.A.G.), Weill Cornell Medicine, New York, New York
| | - A Gupta
- From the Department of Radiology (M.H., Y.W., A.G., T.D.N.)
| | - T D Nguyen
- From the Department of Radiology (M.H., Y.W., A.G., T.D.N.)
| |
Collapse
|
38
|
Tang JSN, Lai JKC, Bui J, Wang W, Simkin P, Gai D, Chan J, Pascoe DM, Heinze SB, Gaillard F, Lui E. Impact of Different Artificial Intelligence User Interfaces on Lung Nodule and Mass Detection on Chest Radiographs. Radiol Artif Intell 2023; 5:e220079. [PMID: 37293345 PMCID: PMC10245182 DOI: 10.1148/ryai.220079] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2022] [Revised: 02/07/2023] [Accepted: 03/02/2023] [Indexed: 06/10/2023]
Abstract
Purpose To explore the impact of different user interfaces (UIs) for artificial intelligence (AI) outputs on radiologist performance and user preference in detecting lung nodules and masses on chest radiographs. Materials and Methods A retrospective paired-reader study with a 4-week washout period was used to evaluate three different AI UIs compared with no AI output. Ten radiologists (eight radiology attending physicians and two trainees) evaluated 140 chest radiographs (81 with histologically confirmed nodules and 59 confirmed as normal with CT), with either no AI or one of three UI outputs: (a) text-only, (b) combined AI confidence score and text, or (c) combined text, AI confidence score, and image overlay. Areas under the receiver operating characteristic curve were calculated to compare radiologist diagnostic performance with each UI with their diagnostic performance without AI. Radiologists reported their UI preference. Results The area under the receiver operating characteristic curve improved when radiologists used the text-only output compared with no AI (0.87 vs 0.82; P < .001). There was no difference in performance for the combined text and AI confidence score output compared with no AI (0.77 vs 0.82; P = .46) and for the combined text, AI confidence score, and image overlay output compared with no AI (0.80 vs 0.82; P = .66). Eight of the 10 radiologists (80%) preferred the combined text, AI confidence score, and image overlay output over the other two interfaces. Conclusion Text-only UI output significantly improved radiologist performance compared with no AI in the detection of lung nodules and masses on chest radiographs, but user preference did not correspond with user performance.Keywords: Artificial Intelligence, Chest Radiograph, Conventional Radiography, Lung Nodule, Mass Detection© RSNA, 2023.
Collapse
|
39
|
Zhang L, Shi Z, Chen M, Chen Y, Cheng J, Fan L, Hong N, Jia W, Jiang G, Ju S, Li X, Li X, Liang C, Liao W, Liu S, Lu Z, Ma L, Ren K, Rong P, Song B, Sun G, Wang R, Wen Z, Xu H, Xu K, Yan F, Yu Y, Zha Y, Zhang F, Zheng M, Zhou Z, Zhu W, Lu G, Jin Z. Study design of deep learning based automatic detection of cerebrovascular diseases on medical imaging: a position paper from Chinese Association of Radiologists. INTELLIGENT MEDICINE 2022; 2:221-229. [DOI: 10.1016/j.imed.2022.07.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/03/2025]
|
40
|
Labus S, Altmann MM, Huisman H, Tong A, Penzkofer T, Choi MH, Shabunin I, Winkel DJ, Xing P, Szolar DH, Shea SM, Grimm R, von Busch H, Kamen A, Herold T, Baumann C. A concurrent, deep learning-based computer-aided detection system for prostate multiparametric MRI: a performance study involving experienced and less-experienced radiologists. Eur Radiol 2022; 33:64-76. [PMID: 35900376 DOI: 10.1007/s00330-022-08978-y] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Revised: 06/16/2022] [Accepted: 06/21/2022] [Indexed: 11/04/2022]
Abstract
OBJECTIVES To evaluate the effect of a deep learning-based computer-aided diagnosis (DL-CAD) system on experienced and less-experienced radiologists in reading prostate mpMRI. METHODS In this retrospective, multi-reader multi-case study, a consecutive set of 184 patients examined between 01/2018 and 08/2019 were enrolled. Ground truth was combined targeted and 12-core systematic transrectal ultrasound-guided biopsy. Four radiologists, two experienced and two less-experienced, evaluated each case twice, once without (DL-CAD-) and once assisted by DL-CAD (DL-CAD+). ROC analysis, sensitivities, specificities, PPV and NPV were calculated to compare the diagnostic accuracy for the diagnosis of prostate cancer (PCa) between the two groups (DL-CAD- vs. DL-CAD+). Spearman's correlation coefficients were evaluated to assess the relationship between PI-RADS category and Gleason score (GS). Also, the median reading times were compared for the two reading groups. RESULTS In total, 172 patients were included in the final analysis. With DL-CAD assistance, the overall AUC of the less-experienced radiologists increased significantly from 0.66 to 0.80 (p = 0.001; cutoff ISUP GG ≥ 1) and from 0.68 to 0.80 (p = 0.002; cutoff ISUP GG ≥ 2). Experienced radiologists showed an AUC increase from 0.81 to 0.86 (p = 0.146; cutoff ISUP GG ≥ 1) and from 0.81 to 0.84 (p = 0.433; cutoff ISUP GG ≥ 2). Furthermore, the correlation between PI-RADS category and GS improved significantly in the DL-CAD + group (0.45 vs. 0.57; p = 0.03), while the median reading time was reduced from 157 to 150 s (p = 0.023). CONCLUSIONS DL-CAD assistance increased the mean detection performance, with the most significant benefit for the less-experienced radiologist; with the help of DL-CAD less-experienced radiologists reached performances comparable to that of experienced radiologists. KEY POINTS • DL-CAD used as a concurrent reading aid helps radiologists to distinguish between benign and cancerous lesions in prostate MRI. • With the help of DL-CAD, less-experienced radiologists may achieve detection performances comparable to that of experienced radiologists. • DL-CAD assistance increases the correlation between PI-RADS category and cancer grade.
Collapse
Affiliation(s)
- Sandra Labus
- Department of Radiology, Helios Klinikum Berlin-Buch, Schwanebecker Ch 50, 13125, Berlin, Germany.
| | - Martin M Altmann
- Department of Radiology, Helios Klinikum Berlin-Buch, Schwanebecker Ch 50, 13125, Berlin, Germany
| | - Henkjan Huisman
- Radboud University Medical Center, Nijmegen, The Netherlands
| | - Angela Tong
- Department of Radiology, New York University Grossman School of Medicine, New York, NY, USA
| | | | - Moon Hyung Choi
- Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea
| | | | - David J Winkel
- Department of Radiology, University Hospital of Basel, Basel, Switzerland
| | - Pengyi Xing
- Department of Radiology, Changhai Hospital, Shanghai, China
| | | | | | - Robert Grimm
- Diagnostic Imaging, Siemens Healthcare, Erlangen, Germany
| | | | - Ali Kamen
- Digital Technology and Innovation, Siemens Healthineers, Princeton, NJ, USA
| | - Thomas Herold
- Department of Radiology, Helios Klinikum Berlin-Buch, Schwanebecker Ch 50, 13125, Berlin, Germany
| | - Clemens Baumann
- Department of Radiology, Helios Klinikum Berlin-Buch, Schwanebecker Ch 50, 13125, Berlin, Germany
| |
Collapse
|